The Therapeutic Potential of Natural Products from \u3ci\u3eVaccinium\u3c/i\u3e Berries for Viral and Lung Diseases Through an Improved LC-MS-Based Chemometric Approach by Petrova, Vanya I.
City University of New York (CUNY)
CUNY Academic Works
Dissertations, Theses, and Capstone Projects Graduate Center
2-2018
The Therapeutic Potential of Natural Products from
Vaccinium Berries for Viral and Lung Diseases
Through an Improved LC-MS-Based
Chemometric Approach
Vanya I. Petrova
The Graduate Center, City University of New York
How does access to this work benefit you? Let us know!
Follow this and additional works at: https://academicworks.cuny.edu/gc_etds
Part of the Analytical Chemistry Commons, Food Chemistry Commons, Medicinal-
Pharmaceutical Chemistry Commons, and the Plant Biology Commons
This Dissertation is brought to you by CUNY Academic Works. It has been accepted for inclusion in All Dissertations, Theses, and Capstone Projects
by an authorized administrator of CUNY Academic Works. For more information, please contact deposit@gc.cuny.edu.
Recommended Citation
Petrova, Vanya I., "The Therapeutic Potential of Natural Products from Vaccinium Berries for Viral and Lung Diseases Through an
Improved LC-MS-Based Chemometric Approach" (2018). CUNY Academic Works.
https://academicworks.cuny.edu/gc_etds/2528
  
 
 
THE THERAPEUTIC POTENTIAL OF NATURAL 
PRODUCTS FROM VACCINIUM BERRIES FOR VIRAL 
AND LUNG DISEASES THROUGH AN IMPROVED  
LC-MS-BASED CHEMOMETRIC APPROACH 
 
by 
 
VANYA I. PETROVA 
 
 
 
 
 
A dissertation submitted to the Graduate Faculty in Biology in partial fulfillment of the 
requirements for the degree of Doctor of Philosophy, The City University of New York 
 
2018 
ii 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2018 
VANYA I. PETROVA 
All rights reserved 
iii 
This manuscript has been read and accepted for the Graduate Faculty in Biology in satisfaction 
of the dissertation requirement for the degree of Doctor of Philosophy. 
 
 
 
___________________  ________________________________________________ 
Date      Chair of Examining Committee 
Dr. Edward J. Kennelly, Lehman College 
 
 
___________________   ________________________________________________ 
Date      Executive Officer 
Dr. Cathy Savage-Dunn 
 
 
______________________________________________ 
Dr. Jeanine D’Armiento, Columbia University 
 
 
______________________________________________ 
Dr. Amy Litt, University of California, Riverside 
 
 
______________________________________________ 
Dr. Moira Sauane, Lehman College 
 
 
______________________________________________ 
     Dr. Prabodhika Mallikaratchy, Lehman College 
    
   
 
Supervising Committee 
 
The City University of New York 
  
 
  
iv 
Abstract 
The therapeutic potential of natural products from Vaccinium berries for 
viral and lung diseases through an improved LC-MS-based  
chemometric approach 
by Vanya I. Petrova 
Advisor: Dr. Edward J. Kennelly 
Smoking is a global epidemic that creates serious health and economic burden. It is the 
primary, preventative factor for the majority of causes of death worldwide. Analysis of publicly 
available data revealed that smoking prevalence rates among the youth in developing countries, 
especially in Bulgaria, were alarmingly high. The Bulgarian population was found to have one of 
the highest percentages of smokers and the second highest rate among teenage girls. 
Consequently, chronic diseases affected by smoking, such as chronic obstructive pulmonary 
disorder (COPD), have been increasing there in the last five years. Poland, on the other hand, is 
an exemplary outlier for the region with much lower smoking prevalence rates and COPD 
incidence growth like those in the developed countries, such as the United States. 
A survey among college-aged people at Lehman College, City University of New York, 
determined that there were behavioral sensitivities predictive of cigarette use. Experimenters 
were highly sensitive to fun seeking and reward responsiveness. A larger portion of the 
experimenters knew people that have COPD but were not related to them. Hispanics were the 
majority within the experimenter group and they seemed to eat antioxidant-rich foods less often 
than others. Therefore, tailored anti-tobacco efforts in developing countries considering 
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behavioral sensitivities of different cigarette use groups are needed to reduce country disparities 
of smoking prevalence and chronic diseases, such as COPD.  
COPD is a disease for which there is no cure and current therapies only temporarily 
control symptoms. Still, evidence suggests a diet rich in polyphenol-rich foods, such as apples 
and berries, may hold a promise in the treatment of the disease. Antioxidant-rich blueberries, 
cranberries, and lingonberries are temperate species in the Vaccinium genus, which produce 
several classes of secondary metabolites potent against aging and chronic diseases, such as 
COPD. A literature review of their chemistry, bioavailability, and bioactivity was conducted. 
Growing consumer awareness of the health-promoting effects of cranberry and blueberry 
compounds combined with trends towards organic farming may offer further areas of growth and 
development for these crops.  
Vaccinium berries have been studied for centuries, but their full potential to ameliorate 
lung and viral diseases remains to be established. These studies focused on a class of berry 
compounds that have not been studied extensively – the oligomeric procyanidins. Procyanidin 
dimer B2 and an A-type trimer were found to counteract smoke-induced responses in airway 
epithelial cells by decreasing an inflammatory marker interleukin 8 (IL-8) and downregulating 
proteolytic enzyme collagenase matrix metalloproteinase-1 (MMP-1). In contrast, procyanidin 
dimer A2 induced inflammation alone. Furthermore, jaboticabin, an anti-inflammatory depside, 
was found in several Vaccinium berries for the first time.  
Procyanidins have low bioavailability and upon ingestion most of these compounds pass 
unabsorbed through the small intestine as they enter the colon where they get metabolized by the 
gut microflora. Consumption of foods rich in procyanidins has been found to impact the 
concentration of certain microbial metabolites. The study investigated four procyanidin 
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metabolites for their anti-inflammatory potency in small airway epithelium, and hippuric acid 
was determined to significantly inhibit smoke-induced IL-8 levels. Other indirect, favorable 
health effects of procyanidin B2 were explored in relation to its ability to modify certain gene 
expression of antioxidant enzymes and epigenetics factors.  
The tested procyanidins were selected with an improved natural product discovery 
approach whose success was further measured by searching for the most antiviral compounds 
from three highbush blueberry cultivars. The approach builds on previous chemometric methods 
which prioritized markers with higher relative abundance in the bioactive samples. The improved 
approach utilized a vast chemical data set from state-of-the-art LC-MS techniques, but reduced 
the number of highest-ranked, potentially active markers. This first improvement was achieved 
by employing very similar samples, such as parallel fractions from the three cultivars. 
Additionally, the approach helped prioritize compounds with strong anti-HSV-1 activity while 
decreasing the priority of markers with weaker antiviral potency. This second improvement 
accounted for different levels of fractions’ antiviral activity by making two separate chemometric 
comparisons among the three fractions and considering only the overlapping markers. Out of the 
tested compounds, quercetin 3-β-D-glucoside was determined to have the strongest viricidal 
effect against acyclovir resistant HSV-1 strain. The study also led to the identification of 
antiviral cinchonain in the fruits of blueberry species for the first time.  
The novel chemometric approach integrates improvements in the analysis of big chemical 
data sets that could make the process of drug discovery from natural products more targeted and 
efficient. Dark-colored berries should be further investigated for other potent antimicrobial 
compounds and oligomeric procyanidins merit additional studies of their pharmacological 
potential for chronic lung diseases.  
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Chapter 1: COPD and its main risk factor, tobacco smoking – 
detrimental effects, sensitivities, and prevalence 
 
1. Chronic obstructive pulmonary disorder (COPD): major cause of death 
The top four leading causes of death in the world in 2015 were ischemic heart disease, stroke, 
lower respiratory infections, and chronic obstructive lung disease, as shown in Table 1.1. 
Table 1.1 Top four causes of death, trend for 2000 – 2015 period worldwide (WHO, 2016) 
 
A preventable risk factor for all four of these diseases is tobacco smoking. As seen in 
Figure 1.1, tobacco smokers have much higher risk of premature morbidity from cancers, 
coronary heart or metabolic diseases, and pulmonary diseases. Over the last fifteen years, 
prevalence rates of tobacco smoking have been declining, yet heart disease has continued to 
increase its contribution to mortality rates worldwide. Therefore, other modifiable risk factors 
associated with prevention of heart disease should be targeted, such as encouraging more 
physical exercise and a diet rich in fruits and vegetables (Chapter 3). Respiratory diseases, on the 
other hand, have not increased their contribution to death over the last 15 years, which is a 
probable result from anti-smoking campaigns. Still, decrease of mortality rates from COPD has 
not been noticeable, since the illness develops over several years and there is a lag between 
smoking cessation and COPD incidence. 
 
2000 2015
Ischaemic heart disease: 13.2 15.5 0.18
Stroke: 10.4 11.1 0.07
Lower respiratory infections: 6.5 5.7 -0.12
COPD: 5.7 5.6 -0.01
% of total deaths
Top 4 causes of death change
2 
 
1.1. COPD pathology and risk factors 
Most COPD cases are caused by cigarette smoke. COPD exhibit a combination of two 
phenotypes: emphysema and chronic bronchitis.  
  
 
Fig. 1.1 Smoking attributable mortality in the U. S. and COPD factors, 2014 (U.S. DHHS, 2014) 
 
Chronic bronchitis is characterized by shortness of breath, mucous coughs, and wheezing. 
Oxidative stress and airway inflammation are the major factors contributing to the disease. 
Inflammatory cytokines multiply reactive oxygen species (ROS) even further, causing a vicious 
cycle (Rahman, 2012). Levels of neutrophil chemotactic factor interleukin 8 (IL-8) are 
significantly higher in COPD patients compared to asthmatic, smoking, and non-smoking subject 
groups (Keatings et al., 1996). IL-8 inhibition by cranberry fractions and compounds in cigarette 
smoke-treated small airway epithelial lung (SAE) cells was tested in Chapter 3.  
Emphysema, on the other hand, results from the loss of function of alveolar tissue 
(Taraseviciene-Stewart et al., 2008), which is thought to be caused by the imbalance of elastin 
and collagen proteases and their inhibitors (Abraham & Hogg, 2010; Gross et al., 1964). 
Cigarette smoke in pulmonary epithelial cells leads to ERK dependent induction of interstitial 
collagenase matrix metalloproteinase- 1 (MMP-1) (Figure 1.2). The matrix metalloproteinases 
SMOKERS
COPD
~19% of COPD:   
occupational exposure 
to pollutants
~80% of COPD: 
tobacco smoking 
~2% of COPD: 
genetics
Smoking Attributable Mortality in the U. S., 1965-2014 and COPD factors
21% Pulmonary 
diseases
43% Cancers
36% Cardiovascular and 
metabolic diseases 
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are involved in the breakdown of extracellular matrix of normal physiological processes. 
Transgenic mice expressing human collagenase MMP-1 develop emphysema-like morphological 
damage in their lungs (D’Armiento, Dalal, Okada, Berg, & Chada, 1992) and MMP-1 is found in 
alveolar cells of emphysema patients, but not in smokers without the disease (Imai, 2001). Gene 
expression assays of MMP-1 presented in Chapter 3 evaluated the effect of cranberry compounds 
on CSE-treated SAE cells. 
Secondary inflammation, imbalance of proteolytic enzymes, and tissue destruction in 
COPD patients are exacerbated by ROS (Austin et al., 2016). One of the main molecules 
involved in the protection of the lung against smoke-induced damage in alveolar epithelial cells 
is the endogenous antioxidant glutathione (GSH). Upregulating the endogenous antioxidant 
system neutralizes the variety of pro-oxidant factors targeting the large surface area of the lungs 
under normal conditions. Smoking disrupts this balance by increasing the oxidant burden leading 
to increased levels of the major cellular thiol antioxidant and redox recycler, glutathione, in the 
epithelial lining fluid. Yet in patients with COPD, levels of GSH have been found to be lower 
than in healthy non-smokers (Drost et al., 2005). Decreased levels of GSH may lead to loss of its 
function as a protective barrier and increased epithelial permeability (Morrison et al., 1999), but 
direct administration of GSH proved unsuccessful because of bronchoconstriction, problems 
with bioavailability, and formation of toxic products (Rahman, 2008). GSH converts hydrogen 
peroxide and lipid peroxides to water and nontoxic fatty acids and becomes oxidized in the 
process. It is then reduced by glutathione reductase (GSR) and its homeostasis is regulated by 
feedback inhibition by GSH on the rate limiting enzyme glutamate cysteine ligase (GCL) and by 
the glutathione redox system. The regulatory subunit of GCL (GCLM), GSR, and glutathione S-
transferase A2 (GSTA2) was found to vary considerably between smokers (Hackett et al., 2003) 
4 
and is suggested to be associated also with aging, relevant for COPD because its prevalence is 
highest in patients older than 65 years (Liu, 2002). Antioxidant compounds from Vaccinium 
berries, such as resveratrol, could exert an antioxidant effect not only by directly scavenging 
ROS from the site of injury, but also by upregulating the endogenous antioxidant enzymes 
involved in GHS homeostasis (Kode et al., 2008). Procyanidin compounds found in Vaccinium 
berries are screened for their effect on expression of GCLM, in Chapter 3.  
Besides smoking, other factors, such as genetics and air pollution, play a role in COPD 
pathology; a majority of smokers develop the disease, but 20% of COPD patients do not smoke 
(Figure 1). Exposure to fumes, chemicals, and dust at home or work could contribute to COPD 
prevalence, especially in developing countries where households use biomass fuel for cooking 
(Salvi and Barnes, 2009). Genetic predisposition also plays a role in developing COPD and has 
been mainly associated with the deficiency of alhpha-1 antitrypsin (A1AT) – an inhibitor of 
enzymes like neutrophil elastase, which breaks down elastin and decreases elasticity of the lungs. 
Patients with PiZZ deficiency of A1AT, predominant in the North-Western European population,  
develop early onset of pulmonary emphysema (Hutchison et al., 2002). Polymorphisms in 
detoxification pathways, such as the glutathione S-transferases, could be protecting smokers who 
remain healthy (Imboden et al., 2007). Furthermore, a recent genome-wide study of interactions 
of single nucleotide polymorphisms by second hand smoke exposure identified three pathways 
underlying susceptibility for COPD, which are also implicated in COPD pathogenesis: the 
apoptosis pathway, p38MAPK pathway, and tumor necrosis factor (TNF) pathway (Figure 1.2). 
The highest interaction was found in the gene coding for KCNH1, which is a voltage-gated 
potassium channel that is highly expressed on mast cells and macrophages in germinal centers of 
reactive lymph nodes (de Jong et al., 2017).  
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Finally, epigenetic factors may also play a role in the onset and progression of COPD. 
Chapter 3 also presents preliminary studies of the influence of cranberry compounds on 
expression of the DNA methylation enzyme DNMT1 as it may lead to downstream 
hypermethylation of EPAS1, EPHX1 in COPD. 
 
Fig. 1.2 Physiological impact from tobacco smoking, related to COPD. Shaded areas were 
investigated in this dissertation work (Anes et al., 2014; Foronjy & D’Armiento, 2001; Rahman 
& Adcock, 2006; U.S.DHSS, 2010; Yoo et al., 2015)  
 
1.2. Tobacco smoking – the primary preventable risk factor for COPD  
Tobacco smoke introduces 98 hazardous components directly to the airways and the 
lungs, many of them reaching the entire body through the bloodstream (Talhout et al., 2011). It 
consists of particulate phase and vapor phase. Recently, the tar and nicotine yields in tobacco 
products have been reduced (Benowitz, 1996; NCI, 2000). Tobacco smoke contains human 
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carcinogens, such as arsenic, benzene, beryllium, cadmium, chromium, and others included in 
the International Agency for Research on Cancer (IARC) Group 1 carcinogens (Smith et al., 
1997). In addition to these toxins, cigarette smoke causes oxidative stress which is the culprit of 
many chronic diseases. Oxidizing agents in smoke play a role in cell membrane lipid 
peroxidation, disruption of the protease balance and release of pro-inflammatory mediators 
through p38 MAPK- and ERK1/2-dependent pathways (Mercer, et al., 2004; Moretto et al., 
2009). The immune response further increases oxidative burden via the NADPH oxidase 
pathway creating a vicious cycle (Panday et al., 2015) (Figure 1. 2). 
2. Smoking habits of college students: survey of students at Lehman College, NY, 2011-2012 
2.1. Survey background and methods 
Cigarette smoking is detrimental to health, but its substantial role in chronic diseases such 
as hypertension and COPD is oftentimes neglected among youth. College students are especially 
predisposed to experiment with cigarette smoking as they become more independent. Studying 
abroad could exacerbate the risk of becoming a smoker if cigarettes are sociably acceptable in 
the new environment. In contrast, if smoking is commonplace in the native country, cigarettes 
smoking may be a coping mechanism for homesickness (Sa et al., 2013). 
A smoking habits survey was conducted among Lehman College students from 2011 to 
2012 just before the campus became smoke-free on July 1, 2012. The survey was part of a 
nation-wide initiative assessing smoking and tobacco use among Hispanic college students at the 
national level, sponsored by the Hispanic Association of Colleges and Universities (HACU) and 
led by the research group of Dr. Raymond Garza and Dr. Michael Baumann at the University of 
San Antonio, Texas. Campuses in four different U.S. states, namely, Florida, California, Texas, 
and New York were chosen to capture larger portion of Hispanic subpopulations, such as Cubans 
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(Florida), Mexicans (California, Texas), and Puerto Rican or Dominican (New York). Lehman 
College was chosen because it is considered a Hispanic-Serving Institution (HSIs) – a higher 
education institution with more than 25% undergraduate full-time students who are Hispanic. In 
the case for Lehman College, Hispanics were at that time predominantly of Puerto Rican and 
Dominican origin.   
The survey was compiled incorporating 20 different question categories ranging from 
demographics to perceptions of health, self-esteem, and social influences and included questions 
from the local researchers at the four campuses. It was administered through a webpage (Survey 
Monkey) which was developed for data collection, storage, and confidentiality. Participants who 
fully completed the survey received compensation in the form of a $20 Amazon gift card.  
IRB approval for Lehman College campus was obtained and an ongoing campus wide 
publicity and recruitment of student participants occurred from 3/23/2011 until 2/24/2012 via 
flyers, classroom announcements, and email lists. Data was cleaned from inconsistent 
responders, and categorical variables were dummy coded, comprising of 1,840 responses (356 
from students at Lehman College, NY). The major findings were published in a paper titled 
“Variation in BAS-BIS profiles across categories of cigarette use” authored by Dr. Michael 
Baumann et. al. (Baumann et al., 2014) and other participating researchers, including me. 
2.2. Major findings from the smoking habits survey 
Presented below are conclusions from the published manuscript based on all data from the 
smoking habits survey. Additionally, the emerging patterns from responses to the survey 
questions are shown, pertaining to health-related activities and COPD awareness. The analysis is 
based on data collected at Lehman College campus only. 
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 Variation in behavioral sensitivities of people according to their cigarette use 
category (Baumann et al., 2014) 
People have different risk of becoming smokers and vary in their likelihood of 
successfully quitting. Results from analysis of the whole data set showed that differences in 
individual sensitivity to threat mitigation, fun seeking, reward responsiveness, and drive are 
predictive to a different extent in relation to cigarette use category. Relationships were based on 
Z scores, which help standardize and compare individual scores from different sets of data. If a Z 
score is equal to the group mean it has a value of 0. If Z score is positive, it is above the group 
mean and if it is negative, it is below the group mean.  
Cigarette use (CU) category was determined based on several questions, capturing the 
frequency and continuation of smoking. Never smokers had smoked less than 10 cigarettes, 
experimenters have smoked more than 10, but less than 100 cigarettes, current smokers have 
smoked more than 100 cigarettes and continue smoking, while former smokers have smoked 
more than 100 cigarettes, but no longer smoke.  
The major conclusions from the survey pertained to behavioral sensitivities predictive of 
cigarette use category (Baumann et al., 2014) and were summarized in Figure 1.3 below Sample 
characteristics and percentage of participants falling into each cigarette use group, by control 
variables could be found in Baumann et al., 2014, Table 1.  
The absolute value of Z represents the distance between the raw score and the population 
mean in units of the standard deviation. Average Z scores were calculated for each behavioral 
aspect by cigarette use category to place all scales on a common metric and reduce risk of 
collinearity (Baumann et al., 2014). The reported z scores were collapsed into three categories, 
low, medium, and high to ease visualization and summarize the main results in Fi 1.3. 
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Fig. 1.3 Levels of sensitivity to behavioral aspects characteristic of cigarette use category (n = 
1940). Average Z scores are grouped into low (z < 0), medium (0 < z < 0.1) and high (0.1 < z < 
0.2) values (Baumann et al., 2014). 
As shown in that figure, non-smokers found mitigation of potential threat very important 
while putting less emphasis on fun seeking. These are also the main differences between people 
who never smoked from experimenters (10 < 100 cigarettes). Therefore, smoking prevention 
efforts could be tailored to decrease fun and increase reward appeal to more effectively 
correspond to greater sensitivities to these behavioral aspects by experimenters. While current 
smokers were low on all four of the above characteristics, former smokers differed from all the 
other cigarette use categories by scoring highest on drive. Thus, smoking cessation efforts 
associated with people’s drive, especially in current smokers, are warranted.  
 Analysis of questions pertaining to health-related activities and COPD awareness  
The focus of this dissertation research is related to health benefits from Vaccinium berry 
compounds on COPD. Students are a relatively young population sample and they may not be 
fully aware of chronic diseases, characteristic for old age, such as COPD. Therefore, Question 1 
below was included to evaluate and promote respondents’ awareness of COPD. Health-related 
Non smoker Experimenter Current Smoker Former Smoker
threat mitigation reward responsiveness drive fun seeking
HIGH
MED
LOW
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activities such as healthy diet and exercise lower risk of chronic diseases, but their preventive 
effect occurs over a longer time-frame, so people need to build healthy habits from a younger 
age. The second question was aimed to evaluate different frequencies of consumption of 
antioxidant-rich foods, with respect to Hispanic, Latino or Spanish origin and cigarette use 
category. 
Question 1: COPD awareness: 
Chronic bronchitis and emphysema (COPD) are mainly caused by smoking. The signs and 
symptoms develop slowly, and include an ongoing cough, shortness of breath, wheezing, and 
chest tightness. Please check all that apply:  
_____ I know someone with such symptoms (know COPD) 
_____ I am related to someone with such symptoms (related COPD) 
_____ I display some of the symptoms (shows smpt) 
_____ I think I am at risk to that disease (at risk) 
_____ I am interested in learning more about this disease (learn more) 
_____ None of the above  
 _____ Refused 
 
The last two choices of Question 1 were filtered out of the analyzed data set so the total 
number of respondents was 157. One participant could check more than one response, so the 
total responses were 217 (Table 1.2).  
Table 1.2 Awareness of COPD among cigarette smoking category  
 
Responses from Question 1 were plotted in Figure 1.4 and were normalized only for 
cigarette use category to better describe the distribution of specific awareness statement across 
different cigarette use categories. 
CU category
Knows a COPD 
(n=90)
COPD relative 
(n=59)
Shows smpt 
(n=8)
At Risk 
(n=8)
Learn more 
(n=52)
Responses 
(217)
Respondents 
(157)
Nonsmoker ( N ) 30 23 2 1 24 80 57
Experimenter ( E ) 41 25 3 1 14 84 60
Current smoker ( C ) 13 5 2 3 8 31 23
Former smoker ( F ) 6 6 1 3 6 22 17
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Fig. 1.4 COPD awareness by cigarette use category (CU). Percent of respondents in each CU 
category who responded to different COPD awareness statements pertaining to question 1 above. 
Data is normalized for CU category. Respondents were not limited to one statement, so the total 
percentage of respondents from all statements per CU category (same color) exceeds 100%. The 
contingency table with the survey data for question 1 is presented in Appendix B.  
  
Figure 1.4 appropriately represents the total number of respondents for each awareness 
statement (e.g., fewer people said they show symptoms or are at risk for COPD, compared to the 
number of people who answered that they know someone with COPD symptoms). Current and 
former smokers differed from experimenters in their desire to learn more about the disease and in 
recognizing they could be at higher risk of COPD. Experimenters, on the other hand did not 
think they could be at risk t of developing COPD and were least interested in learning more 
about the disease.  
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Fig. 1.5 COPD awareness relative to 
association with a COPD patient. 
Summary of responses for COPD 
awareness statements pertaining to 
knowing or being related to a person 
with COPD, grouped by active 
smokers (experimenters and current 
smokers) and not active smokers 
(nonsmoker and former smokers) 
from question 1 above (data table in 
Appendix B).  
 
 
  The percentage of nonsmokers that know a person with COPD and have a relative with 
COPD was similar (Figure 1.4). Likewise, the distribution of former smokers of knowing and 
being related to a COPD patient was almost the same. In contrast, a much larger part of active 
smokers (experimenters and current smokers) knew someone with COPD symptoms, than the 
active smokers who were related to a person with COPD. Therefore, smoking status could be 
dependent on having a relative with COPD (Figure 1.5). Such notion is supported by a high 
individual's concern over the negatives of smoking, which may discourage initiation or 
continuation of tobacco use, discussed above and in Figure 1.3 (Baumann et al., 2014). The 
opposite association (having a relative with COPD dependent on smoking status) is less likely 
supported by literature that reports a strong risk factor for COPD to be family history of COPD, 
independent of family history of smoking (Hersh et al., 2011).  Still more research is needed to 
confirm the specific association of COPD with smoking status, but increasing the awareness of 
risk factors and pathology of COPD could be an important aspect of future anti-tobacco 
campaigns.  
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Next, participants were asked Question 2 to determine their frequency of health-
promoting activity, related to diet, exercise, and acupuncture and they had to check one of the 
boxes in each row. Data was filtered to exclude respondents who answered didn’t know/not 
sure to the above question and the remaining 357 responses were further normalized by the total 
number of people in each activity to compare frequency patterns of each activity.  
 
Fig. 1.6 Frequency of health-related activities, normalized for each activity.  
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Most respondents never did any of the listed activities (Figure 1.5). The three least 
frequent activities were having acupuncture treatment, taking botanical supplements, and doing 
yoga, all of which have been associated with improved COPD symptoms (Liu et al., 2014; Ram 
et al., 2011; Suzuki et al., 2012). Some interesting trends emerged from analysis of the other 
frequency responses besides “Never”. Taking vitamins and doing exercise was mostly daily, 
while eating foods rich in anti-oxidants (e.g., berries) and omega 3 fats (e.g., salmon or nuts) 
occurred predominantly on a weekly basis. A small number of people did yoga overall, either 
daily or monthly. Even fewer people replied that they took supplements, most of whom did so 
once a week. 
Aligned with this dissertation thesis research focus, the frequency of antioxidant-rich 
food consumption was analyzed by cigarette use category and Hispanic, Latino, or Spanish 
origin. Responses from the following survey question helped determine the origin of the 
respondents.  
Question 3. Question about Hispanic, Latino, or Spanish origin: 
 
Mexican and Cuban respondents were less than 10 people each, so they were grouped 
together with those of another Hispanic, Latino, or Spanish origin. Totally, there were 52 Puerto 
Rican (PR), 73 Dominican (D), 40 other Hispanic, Latino or Spanish (OH), and 191 other, non-
Hispanic, Latino, or Spanish (NH) respondents included in the analysis.  
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Comparison among the cigarette use category among Hispanics (n = 165), revealed a 
much lower percent of them were nonsmokers (42%) compared to all other non-Hispanics 
(51%). The percentage of experimenters who were Hispanic was much greater (41%) than the 
portion of experimenters who were non-Hispanic (26%). Within each Hispanic subgroup, 38% of 
all Dominicans and 31% of all Puerto Ricans were experimenters. These results suggest smoking 
prevention campaigns should target the young Hispanic population, especially Dominicans.    
 
Fig. 1.7 Cigarette use category among Hispanics (n = 165) and not Hispanics (n = 191). 
Current and former smokers were a smaller percentage among Hispanics compared to 
non-Hispanics, but the relatively young age of the subjects (college students) should be noted 
when drawing any conclusions on these differences, as with time, experimenters have high 
probability of becoming current smokers.     
Anti-oxidant rich food consumption frequency among non-Hispanics (n = 191) and 
different subgroups of Hispanics (n = 165) was analyzed. Compared population groups differed 
in number of respondents so data was normalized for cigarette-use category and origin for each 
subpopulation. Experimenters and current smokers were grouped together in a category called 
active smokers and were compared to nonsmokers and former smokers. 
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Fig. 1.8 Frequencies of antioxidant-rich foods consumption among Puerto Ricans, Dominicans, 
people of non-Hispanic origin and other Hispanic, Latino or Spanish origin, normalized by 
cigarette use category and ethnic origin (total number of each normalized group is shown in 
parenthesis). Maximum value of y-axis is 0.5 for all graphs to ease comparisons, between 
majority of the frequencies, which range from 0 to 0.5. If higher than 0.5, the respective 
frequency number is shown with an arrow. Frequencies are designated with capital letters: D – 
once a day, W – once a week, M – once a month, Q – once every 3 months, N- never.   
 
Most respondents across cigarette use category and origin said they never consumed high 
antioxidant foods, which may be related to their confusion of what these foods are and, therefore, 
referring only to the given examples: cranberries and blueberries, which do not grow in Puerto 
Rico and the Dominican Republic. Numbers above 0.5 (50%) were due to small sample size 
(Dominican former smokers, n=1; other Hispanic nonsmokers, n=4 and former smokers, n=6) 
(Figure 1.8) and were not used for any conclusions. 
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Aside from respondents who said they never consumed antioxidant-rich foods, some 
interesting trends appear from the responses. For the non-Hispanic group, most people said they 
eat antioxidant-rich foods daily and the number of respondents decreased with decreasing 
frequency of consumption (D>W>M>Q) across all cigarette use category. Interestingly, the 
frequency pattern among active smokers in the other Hispanic, Latino, and Spanish group was 
more similar to the trend in the non-Hispanic group rather than those of the Dominican or Puerto 
Rican groups. (Figure 1.8). More importantly, a majority of Puerto Ricans and Dominicans 
responded that they consume antioxidant foods monthly (first or second largest portion across all 
cigarette use categories), while in the other two groups the percentage of monthly consumption 
came in third place (after daily and weekly). More Dominicans reported that they consume 
antioxidant-rich foods more often than Puerto Ricans: Dominican active smokers – mostly once 
a day and nonsmokers – once per week, while a majority of Puerto Ricans – once per month. 
 Interestingly, out of those who said they never eat berries or anti-oxidant rich foods, 
there was a large portion of Puerto Ricans who were current smokers. A substantial portion of 
Puerto Ricans, who were former smokers, reported monthly consumption of such foods. A large 
percentage of Dominicans were experimenters and reported eating anti-oxidant rich foods mostly 
daily or monthly. Dominican nonsmokers reported predominantly weekly consumption of anti-
oxidants. 
2.3. Conclusions 
COPD is a major cause of death and disability and its primary risk factor is tobacco 
smoking. The survey among college students conducted as part of this research at Lehman 
College, NY from 2011 to 2012 shows differences in COPD awareness with respect to the 
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cigarette use category. The most interesting trend observed based on our analysis is that having a 
relative with COPD may be negatively correlated to active smoking status. 
The data showed lower rates of current and former smokers among Hispanics compared 
to non-Hispanics. Still, a published report on another survey from 2012 found the highest 
smoking and obesity rates among Puerto Rican participants and the lowest in Dominicans among 
Latinos and Hispanics living in the U.S. (Daviglus et al., 2012), which was supported by our 
data. Yet, a large portion of Hispanics (especially Dominicans) were experimenters (age group 
18-25 years old) that may have a high probability of becoming current smokers (>100 
cigarettes). The manuscript from this survey outlined major behavior sensitivities for each 
cigarette use category and experimenters scored high on fun seeking and reward responsiveness.    
Foods rich in anti-oxidants may help counteract the effects of smoking and prevent 
chronic diseases (Chapters 2 and 3). Our data shows that from the people who consume 
antioxidant-rich foods, Dominicans and Puerto Ricans eat such foods less frequently than other 
Hispanic and non-Hispanic groups.  
In the future, health-promoting campaigns should focus on (i) raising the awareness about 
chronic diseases, such as COPD, based on a sentiment of having a relative with the disease, (ii) 
decreasing the perception of fun and reward, which are important factors for experimenters, and 
(iii) encouraging more frequent consumption of antioxidant rich foods. 
3. Smoking prevalence and COPD trends in developing countries, with focus on Bulgaria 
3.1. Background 
Tobacco smoking prevention and cessation have several clinical and economic benefits. 
Positive outcomes of tobacco-control programs have been achieved in the U.S. through 
legislation around smoke-free work places and increased tobacco products’ tax rates as well as 
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media and community campaigns. In 2015, Europe had the highest regional average prevalence 
(27.3%) of tobacco smoking among persons 15 years of age and older and its Eastern European 
countries ranked among the top in cigarette smoking rates (IHME, 2016).  
The World Health Organization (WHO) reports that increasing taxes on tobacco products 
is one of the most effective measures to reduce tobacco use, yet only 9% of low and middle-
income countries have sufficiently implemented this strategy (taxes that total to more than 75% 
of retail price) (WHO, 2015). Although Bulgaria recently implemented a tax rate of 82% over 
the retail price, smoking prevalence in its population remains one of the highest in the world and 
further efforts need to be taken, especially targeting young people. Cigarette smoking is unlikely 
to occur if it is not started during adolescent years, which is why prevention of smoking should 
target the youth (Garfinkel, 1997). Studies have explored demographic factors, such as age, 
gender, race, and ethnicity as well as socioeconomic status as contributors to people’s choice to 
start or quit smoking. There are also behavioral differences that may play a role. Successful 
prevention and cessation programs should find the most appropriate routes of implementation 
and customized approach according to their target audience.    
Although global rates of tobacco smoking are declining, the total number of smokers is 
increasing due to population growth (Ng et al., 2014). Furthermore, tobacco smoking rates in 
developed countries are decreasing, while those in developing countries, such as Bulgaria, are 
increasing (Jha & Chaloupka, 2000). Finally, education on healthy dietary choices and effects of 
smoking and encouragement of physical exercise could be effective complementary measures to 
fight chronic diseases. 
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3.2. Smoking prevalence and COPD comparisons among Bulgaria, Poland, and U.S.A. 
Publicly available data from the Institute for Health Metrics and Evaluation (IHME, 
2016; IHME, 2017) was used to draw comparisons between tobacco smoking related statistics 
among a developed country, the U.S., and two mid-income countries, Poland and Bulgaria. The 
last two countries are located in Southeastern Europe and are now part of the European Union, 
also sharing a history of being communist and large tobacco producers. Despite their similarities, 
Bulgaria and Poland differ substantially in their current smoking prevalence rates.  
COPD onset usually occurs in people 50 years of age or older with a history of tobacco 
smoking. Thus, the expected trend in smoking-attributable diseases such as COPD was assessed 
by screening the daily smoking prevalence of people aged 45-49 for the latest available year 
(2015) among different countries. The map below (Figure 1.9) shows Bulgaria and other 
Southeastern European countries exhibiting some of the highest smoking prevalence rates in the 
world for people between 45-49 years of age. This gives a good picture of the time lag between 
implemented anti-tobacco policies and their effect in decrease of smoking prevalence rates and 
smoking-attributable diseases. In the 1980s, this age group of people (45-49) were in their early 
twenties. At that time, Poland and Bulgaria were communist countries with high rates of tobacco 
smoking and almost no anti-tobacco campaigns. In contrast, smoking prevalence rates in the U.S. 
were decreasing (< 30% in 1987) as a result of anti-tobacco smoking initiatives that had started 
in 1964 with the first report on the health consequences of smoking by the advisory committee of 
the Surgeon General of the public health service. COPD incidence rates have plateaued for the 
U.S. in recent years, while they are still increasing at a rate of 1.2% annually in Bulgaria (Table 
1.3). Poland successfully initiated strong anti-tobacco campaigns in the 1990s, and as a result 
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smoking prevalence rates in the 45-49 age group in Poland are not as high as those in Bulgaria, 
and are half of the rate in Bulgaria when the youngest age group (10-14) is analyzed (Table 1.3). 
 
Fig. 1.9 Daily smoking prevalence for people 45-49 years of age, both sexes, 2015 
To evaluate the expected health burden from COPD in the selected countries, the recent 
trend (rate change for the last 5 years) in COPD incidence (new cases) was analyzed. Health data 
gathering and sharing have not been adequate from Bulgaria in the past, but have improved over 
the last 4 years (WHO, 2015), which is why such a short time period was selected. Furthermore, 
different life expectancies for the selected countries would lead to misguiding results if COPD 
prevalence and death rates were used in the comparison. Oftentimes even though people have 
stopped smoking the disease progresses with its onset at about 50 years of age, therefore, 
incidence of COPD in the 45-49 age group was chosen to be compared (Table 1.3).  
From our survey, most people reported to had tried their first cigarette before the age of 
17. The current analysis showed that the Bulgarian teenage population had one of the highest 
smoking prevalence rates in the world and its youngest population (10-14 age group) ranked 
third in smoking prevalence rates.  
https://vizhub.healthdata.org/tobacco/
Bulgaria (44.7%)Poland (34.2%)USA (17.3%)
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Table 1.3 Daily smoking prevalence rate (%) for various age groups, 2015, and COPD incidence 
rate change from 2010 to 2015 (IHME, 2016) 
 
Moreover, smoking prevalence for females in Bulgaria was the second highest for the 
young adult age groups 20-24 (40%) and 24-29 (44%). This is of high concern considering the 
twenties tends to be the child-bearing age and Bulgaria is one of the countries with negative 
population growth. To further investigate the relationship between gender and smoking 
initiation, smoking prevalence rates in Bulgaria, Poland, and the U.S. were analyzed by gender 
for the teenage population, 15-19 years of age (Figure 1.10). 
 
Fig. 1.10 Daily smoking prevalence rates for people 15-19 years of age by gender, 2015 (IHME, 
2017) 
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Female smoking prevalence rates in Bulgaria (age group 15-19) were higher than male 
ones, which is one of few such cases for all age groups and countries in the world. Worldwide, 
Bulgaria ranks second highest for female smoking rates for age group 15-19 (after Greenland). 
Smoking prevalence rates for that teenage group (15-19) in the U.S. are similar for both males 
and females and are one of the lowest ones as could be expected from a developed country with 
long-time anti-tobacco campaigns. Interestingly, smoking prevalence rates in Poland were more 
in line with these from the U.S. than the ones from Bulgaria, but had larger gender disparity with 
more male smokers than female ones. 
3.3. Recommendation for smoking prevention and cessation programs in Bulgaria 
Smoking rates among young people in Southeastern European countries, such as Bulgaria 
are alarming and smoking cessation strategies need to become state priorities to ameliorate the 
future economic and health burden from smoke-related diseases. Positive outcomes of tobacco-
control programs have been achieved in Poland and the U.S. through legislation around smoke-
free work places and increased tobacco products’ tax rates as well as media and community 
campaigns.  
Different behavioral sensitives predictive of smoking status were determined from our 
survey on smoking habits among college-aged people (Baumann et al., 2014). The experimenter 
category likely characterizes the teenage smoking population in Bulgaria as our data shows most 
subjects tried their first cigarette before 17 years of age. Therefore, school-aged children would 
be more likely influenced by smoking cessation strategies that diminish the perception of fun and 
reward of smoking. Furthermore, nonsmokers from the survey showed high response to 
mitigation of the threat from smoking. A study on Bulgarian youth with respect to smoking 
cessation and initiation confirms these results emphasizing the impact of higher temptations to 
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smoke and the belief that smoking is not so harmful (Anatchkova et al., 2006). Effective public 
health programs targeting the youth in Bulgaria should consider channels of digital media (Brinn 
et al., 2010). The young population of Eastern European countries have high Internet access and 
usage rates so Internet-based smoking prevention programs focused on the youth, combined with 
media and school components, could yield positive outcomes (Park et. al., 2015). 
Low birthrates contribute to Bulgaria’s shrinking population and smoking while pregnant 
doubles the risk of stillbirth. Therefore, the high prevalence of smoking in Bulgarian women in 
their twenties, which is the best childbearing period, calls for immediate action. A future 
decrease in the labor force is going to be inadequate in sustaining even higher government costs 
associated with old-age diseases and early disability, from chronic diseases, such as COPD. 
People who smoke in their twenties would likely fall in the current smoker category from our 
survey, so this population segment would be less sensitive to any of the discussed behavioral 
aspects: threat mitigation, drive, fun seeking, and reward responsiveness. Therefore, other anti-
smoking strategies should be explored from other successful examples in the region, such as that 
from Poland (Jassem et al., 2014).  
Anti-smoking campaigns in Bulgaria have been inadequate and attempts for a smoking 
ban in public spaces have been ineffective due to lack of appropriate enforcement (Anatchkova, 
et al., 2006). Therefore, social perceptions and acceptance of anti-tobacco policies should be 
targeted by national media and community campaigns highlighting the threat and dispelling the 
fun of smoking, with a special focus on the younger population.   
4. Future research: marijuana smoking 
Marijuana legalization could halt the trend of decreasing smoking rates in the U.S. 
Cannabis is a plant that has been used for medicinal purposes or as a recreational drug mainly for 
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its psychoactive component, (−)-trans-Δ9-tetrahydrocannabinol (THC). Still, smoke from 
marijuana and tobacco contain similar carcinogens (Moir et al., 2008), which may position 
marijuana as a risk factor for COPD and/or lower respiratory diseases. Studies have shown that, 
if concurrently used with tobacco smoking, marijuana leads to increased airway inflammation in 
younger people and greater risk of COPD progression in people who are 40 years of age and 
older (Roth et al., 1998; Tan et al., 2009). However, when used alone, studies show no 
association with COPD. Marijuana lacks nicotine, which is what makes tobacco addictive, and 
marijuana users smoke a lower quantity of cigarettes per day in comparison to tobacco cigarette 
smokers (Tashkin, 2013).  
Still, marijuana smoking results in a loss of cilia and an increase in mucous secretions, 
thus compromising the lung’s first line of defense against infection. This airway injury combined 
with the immunosuppressive effects of THC could increase rates of lower respiratory diseases 
(Tashkin, 2013). Interestingly, a case study of uncommon Herpes simplex virus (HSV) 
respiratory infection associated with habitual marijuana smoking was reported recently (Jassem 
et al., 2014). Therefore, marijuana smokers should avoid smoking while having an active HSV-1 
lesion on the mouth. Another preventive measure of lower respiratory infections may be dietary 
natural products with antiviral properties (Chapter 4). Studies of the contribution of marijuana 
smoking to opportunistic respiratory infection are inconclusive (Tashkin, 2013), therefore further 
studies on long-term effects of marijuana smoking are necessary (Gates et al., 2014).  
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Chapter 2: Production, consumption and therapeutic potential of 
blueberries and cranberries 
 
Note: A review article “Blueberries: A "Super Fruit" Complement to Cereals” has been 
published previously in Cereal Foods World (Petrova & Kennelly, 2013). As the first author, I 
conducted independent, literature research and wrote the review, creating original tables and 
figures, also displayed below in Chapter 2. Dr. Kennelly edited the manuscript and is the 
corresponding author.  
 
1. Blueberry and cranberry U.S. production and consumption 
Consumption of blueberries in the U.S. has grown considerably along with research on 
their health benefits. In a survey of the antioxidant capacity of common foods, blueberries ranked 
at the top (R. L. Prior et al., 2003) and, as a result, have been classified in the popular literature 
as a “super fruit” (Wu et al., 2004). Blueberries are one of the largest berry crops grown in the 
U.S., with a total value of $811 million in 2015 (NASS, 2016). The two species of blueberries 
sold commercially in the U.S. are highbush (Vaccinium corymbosum) and lowbush (Vaccinium 
angustifolium) blueberries. 
 
Fig. 2.1 Comparison of highbush and lowbush blueberry industry in the U.S.: Utilized 
production, export and import (in pounds) and price (per pound) (Petrova & Kennelly, 2013; 
NASS, 2016; USDA, 2016) 
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Highbush blueberry (V. corymbosum) is widely available year-round in U.S. grocery 
stores due to widespread production in the United States, Canada, and South America. Its large 
fruits and tall bushes make the highbush blueberry a favored crop of farmers in the states of 
Michigan and New Jersey, which are among the largest producers in the U.S.  
Lowbush blueberries (V. angustifolium) are native to the northeastern U.S. and today are 
also grown commercially, especially in Maine. Due to their smaller size and intense flavor and 
aroma, lowbush blueberries are marketed as “wild blueberries.” These blueberries have a higher 
antioxidant capacity than highbush blueberries (Prior et al., 2003) and are mostly sold frozen 
after the harvest season is over. Freezing the berries preserves their polyphenol content and 
related health benefit, yet it lowers their price. Further price pressures from supply from Canada 
have led to a decreased price of frozen lowbush blueberries to a quarter of the price of their fresh 
counterparts (Figure 2.1). The U.S. Department of Agriculture has started buying the surplus 
lowbush blueberry crop to help producers, but this policy is not sustainable in the long run 
(Whittle, 2016). An alternative solution may be organic farming as consumer interest in organic 
products has been growing and organic production often leads to higher profits for farmers 
(Shea, 2016).  While 3% of cultivated highbush blueberry production is certified organic, less 
than 1% of lowbush blueberry and cranberry production is organic (USDA, 2014). In addition, 
blueberries rank 14th  on the list of fruits and vegetables with the highest pesticides residue and 
unlike apples or cucumbers, they cannot be peeled before consumption (EWG, 2016). Therefore, 
domestic lowbush blueberry sector may benefit from organic production and offer the consumer 
a more anti-oxidant, pesticide-free, longer lasting frozen berries at competitive prices to fresh 
highbush blueberries. Better marketing of the greater health value of frozen, smaller, lowbush 
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blueberries and product novelty may increase the outlook of the lowbush blueberry sector 
(Figure 2.1).  
The major part of blueberry imports though consists of fresh highbush blueberries from 
Chile during the winter months in the northern hemisphere.  Efforts to prolong the domestic fresh 
fruit supply within the U.S. have yielded the creation of northern and southern varieties of 
blueberries through successful hybridization of the eastern United States highbush blueberry 
with lowbush and rabbiteye blueberry species, respectively. 
Rabbiteye blueberries (Vaccinium ashei) are indigenous to the southeastern U.S. and 
have recently been hybridized and grown in southern states to produce berries that are much 
larger and firmer, which is an important quality for harvesting, storage, and marketability 
(Ehlenfeldt & Martin, 2002). The U.S. is also a big exporter of blueberries, mainly to Canada.  
Cranberries (Vaccinium macrocarpon) are also exported widely, but mostly in the form 
of juice to the Netherlands and as prepared or preserved products to different parts of the world 
(Figure 2.2).  
 
Fig. 2.2 Cranberry industry in the U.S.: Utilized production, export and import (in pounds) and 
price (per pound). ( Petrova & Kennelly, 2013; NASS, 2016; USDA, 2016) 
 
0
50
100
150
200
250
Cranberry Utilized Production, Export and 
Import
Utilized Production
Export
Import
1
,0
0
0
,0
0
0
 (
B
ar
re
ls
)
$62/brl - Fresh
$30/brl - Processed
29 
Cranberries’ tart flavor makes them more appealing after some sort of processing, which 
also cuts their price in half compared to fresh berries. Most imported cranberries come as fresh 
or frozen from Canada.  
2. Health benefits of berry polyphenols 
Blueberries, cranberries, and lingonberries belong to the diverse Vaccinium genus of the 
plant family Ericaceae, which includes other familiar berries, such as bilberries and many exotic 
species found in the neotropical region of the Americas (Dastmalchi et al. 2011). Cranberries (V. 
macrocarpon) are a North American Vaccinium berry utilized by Native Americans for their 
ability to delay lipid oxidation in meat preservation techniques (Kä et al., 1999). Cranberries 
naturally have little sugar and what they do have is in the form of glucose, which is considered a 
healthier alternative to fructose (Stanhope et al., 2009). However, because of its tartness, 
cranberries usually are consumed as juice or dried fruit with added sugar, offsetting their low 
sugar content. Commercially grown blueberries and cranberries (Figure 2.3) have become 
popular berry crops as consumers became aware of their nutritional value to diet; not only do 
they add vitamins, minerals and only low levels of sugars and fats, but they are rich in anti-
oxidant polyphenols, such as anthocyanins and procyanidins (Kä et al., 1999). 
 
Fig. 2.3 Blueberry field (A) and cranberry bog (B) at the Philip E. Marucci Center for Blueberry 
and Cranberry Research, Chatsworth, NJ. (C) Vaccinium corymbosum flowers 
Photo credits: Vanya Petrova 
A CB
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The antioxidant and anti-inflammatory properties of berries have been researched widely, 
but health claims should be made only after absorption, metabolism, and bioactivity data has 
been matched to specific compounds and their respective quantities in the food sources. The 
biological effects of selected compounds from each polyphenol class and their respective 
quantity in fresh berries have been summarized in Figure 2.4. Health benefits of berries stem 
mainly from their high polyphenol content. Plant polyphenols have been associated with 
decreased risk of cardiovascular disease (Vita, 2005), cancer (Wang et al., 2011), and obesity 
(Prior et al., 2010).  Polyphenols are a diverse group of organic secondary metabolites that 
contribute to the flavor, color, and nutritional properties of fruits. There are simple polyphenol 
molecules, such as phenolic acids and stilbenes, as well as more diverse and complex ones, such 
as flavonoids (Figure 2.4). Although flavonoids (e.g., anthocyanins and proanthocyanidins) have 
shown strong antioxidant and anti-inflammatory properties in vitro (Kä et al., 1999), poor 
absorption and rapid degradation of some flavonoids suggests they also have an indirect health 
impact, such as activating enzymes that rid the body of toxins and improving gut microflora 
(Lotito and Frei., 2006). 
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The chemical structure of flavonoids usually consists of two aromatic rings linked by an 
oxygen containing heterocycle, but chemical variation in bonds and functional groups subdivides 
them further into more categories, among which are the anthocyanins and the proanthocyanidins 
(Figure 2.5). Other less abundant classes of polyphenols in the Vaccinium fruits such as stilbenes 
(e.g., resveratrol and pterostilbene) and flavonolignans (e.g., cinchonain) may contribute to the 
berries’ health potential and as such merit further investigation.  
 
Fig. 2.5 Chemical structures of selected polyphenolic compounds, including anthocyanins (1-3), 
procyanidin dimers (4-5), catechin (6), and stilbenes (7-8). (Petrova & Kennelly, 2013) 
 
3. Vaccinium berry bioactive compounds: structure, bioavailability and bioactivity  
3.1. Anthocyanins  
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Chemistry: Anthocyanins comprise the highest concentration of all phenolic subgroups in 
the blueberry (Gao & Mazza, 1995). They are the water soluble compounds responsible for the 
blue color in blueberries (Prior et al., 2010); however, these secondary metabolites also 
contribute to the red and purple colors. Anthocyanins accumulate mainly in the skin of the berry, 
protecting the fruit from ultraviolet radiation and temperature stress. Their core structure is a C6-
C3-C6 carbon skeleton, but they differ from other flavonoids by having a positive charge 
(Figure. 2.5). When anthocyanins lose their attached sugar groups, the compounds are called 
anthocyanidins (or anthocyanin aglycones), but as such they are very unstable and rarely found 
in plants. The sugar group improves the stability and solubility of anthocyanin molecules.  
Bioavailability: Anthocyanins are not stable under neutral pH and degrade easily which 
may explain their low bioavailability compared to other flavonoids. Anthocyanins aglycons are 
much better absorbed than their glycosylated forms, but small amounts of intact anthocyanins 
have been found in human subjects after oral consumption of blueberries. Intake of freeze-dried 
lowbush blueberry powder together with a high fat meal achieved maximum blood serum levels 
of anthocyanins four hours after ingestion. The most abundantly present anthocyanins were 
malvidin 3-galactoside, malvidin 3-glucoside, and delphinidin 3-glucoside (Mazza et al. 2002). 
An in vitro study confirmed anthocyanins with glucose groups were favorably transported 
through intestinal cell monolayers compared to other sugar moieties (Yi et al., 2006). Lowbush 
blueberries contain the highest amounts of malvidin glucoside (26 mg/100 g of fresh fruit), while 
highbush blueberries and cranberries contain abundant amounts of delphinidin and cyanidin 
galactosides, respectively (Neveu et al., 2010). In pigs, anthocyanins with either an attached di- 
or tri-glycoside were excreted in the urine intact, while monoglycosides other than the glucoside 
were metabolized via methylation and/or glucuronide formation (Wu et al. 2005). Under 
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physiological conditions, some anthocyanins are recovered as glucuro- and sulfoconjugates in 
human urine (Felgines et al., 2003) but large portions of ingested anthocyanins are likely to 
degrade to their phenolic acids and aldehyde constituents in vivo (Woodward et al. 2009). 
Anthocyanin glucosides could also undergo hydrolysis by the saliva or gastrointestinal enzymes 
to form their respective, more bioavailable aglycons (Walle et al. 2005). Yet, it has been 
suggested that more stable anthocyanin degradation products and microbial metabolites may also 
be responsible for bioactivities and further research is essential in this area (Scalbert et al., 2005).   
Bioactivity: Anthocyanins have antioxidant properties in vitro (Johnson et al. 2013), but 
there is a significant positive correlation between serum anthocyanin content and postprandial 
antioxidant status of blood serum (Mazza et al., 2002). Besides high anti-oxidant activity, an 
anthocyanin in the blueberry – delphinidin 3-glucoside – decreases expression of inflammatory 
marker interleukin 8 and marker matrix metallopeptidase 1 in smoked exposed lung cells 
(Dastmalchi et al., 2011). Anthocyanins may fight oxidative stress and inflammation, and as such 
play a role in the pathogenesis of many chronic diseases, such as chronic obstructive pulmonary 
disease (COPD), but further research is needed to determine their efficacy and mechanism of 
action. In addition to their antioxidant and anti-inflammatory activities, anthocyanins are 
believed to help with depression (Dreiseitel et al., 2009) and lower the risk of obesity (Prior et 
al., 2010) even at low amounts. Dreiseitel et al. showed that anthocyanins and their aglycons 
could inhibit the mitochondrial enzymes, raising the levels of monoamines such as serotonin in 
brain tissue. As a result, a serving of anthocyanin-rich blueberries may help keep serotonin levels 
up and contribute to feelings of well-being and happiness (Meyer et al., 2006). Furthermore, 
anthocyanins have also been shown to enhance memory (Andres-Lacueva et al., 2005). 
Neuroprotection by anthocyanins could stem from their ability to cross the blood-brain barrier, as 
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shown in aged rats, and to trigger additional biological antioxidants in neural cells by inhibition 
of the ASK1–JNK/p38 pathways. Other protective function of anthocyanins, related to obesity, 
was revealed by the decreased fasting serum glucose, leptin levels, and epidydimal adipose tissue 
weights of mice fed with a high-fat diet after the addition of anthocyanins (R. Prior et al., 2010). 
Additionally, anthocyanins may fight oxidative stress and inflammation, which play a role in the 
pathogenesis of many chronic diseases, such as chronic obstructive pulmonary disease. An 
anthocyanin in the blueberry – delphinidin 3-glucoside – has a high antioxidant activity and 
decreases expression of disease markers MMP-1 and IL-8 in smoked exposed lung cells 
(Dastmalchi et al., 2011).   
3.2. Acylated anthocyanins  
Acylated anthocyanins have been less studied although they are present in many plants 
including blueberries. They are more concentrated in lowbush blueberries comprising up to 32% 
of the their total anthocyanin content, but presence in some cultivars of highbush blueberries 
(Bluecrop) has also been detected (Gao & Mazza, 1995; Mi et al., 2004). 
Chemistry: The acylation group may contain an aromatic ring (cinnamic acids) or not 
(aliphatic acids) often bound to the sugar moiety of the anthocyanin. Malvidin 3-O-(6-O-acetyl-
β-D-glucoside) is the most abundant acylated anthocyanin in the blueberry, where an acetyl 
group is attached to the glucose (Mazza et al., 2002). Along with its nonacylated molecule, it 
gives the bluish-red color of blueberries (Giusti & Wrolstad, 2003). Many other, more complex 
acylation patterns exist, which are beyond the scope of this work. 
Bioavailability: Acylated anthocyanins were present intact in humans after oral 
consumption of blueberries but with even lower recovery rates compared to non-acylated 
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structures (Mazza et al., 2002). The metabolism and functions of these forms of anthocyanins in 
human subjects require further studies. 
Bioactivity: Acylation increases stability, while decreasing polarity and water solubility. 
Acetylated anthocyanins have been explored for their ability to provide natural food colorants as 
they possess higher color stability to pH changes (Giusti & Wrolstad, 2003). Color is an 
important factor in food appeal and consumer awareness of synthetic additives to their food has 
unlocked interest in natural colorants. At very acidic conditions, the red flavylium cation in 
anthocyanins is stable. At higher pH levels, formation of the colorless hemiketal and chalcone 
forms is reduced by co-pigmentation and self-association reactions giving a violet hue to the 
color (Pina et al. 2015). Blueberry acylated anthocyanins involve mainly mono- and di-
glucosides which provide limited stability, but greater stability has been observed in 
polyacylated anthocyanins present in radishes and red potatoes (Giusti & Wrolstad, 2003). 
Acetylated anthocyanins could be potential healthier alternative to food additives in achieving 
desirable color so further studies are needed to investigate their physiological function in vivo. In 
rats, plasma antioxidant capacity was significantly elevated after oral administration of purple-
fleshed sweet potato anthocyanin concentrate (Suda et al., 2002). Acylated anthocyanins strongly 
inhibited maltase but not sucrase and therefore they could interfere with carbohydrate digestion 
and improve blood sugar control. They were more potent inhibitors compared to the 
corresponding deacylated anthocyanins (Matsui et al. 2001). Finally, acylation of anthocyanins 
with organic acids markedly increased antimutagenicity of the anthocyanin pigments as 
compared with the deacylated structures (Yoshimoto et al. 2001). 
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Fig. 2.6 Chemical structure of the acylated anthocyanin malvidin 3-O-(6-O-acetyl-beta-D-
glucoside) 
 
3.3. Stilbenes  
Chemistry: Stilbenes make up a class of polyphenolic compounds that consist of aromatic 
groups bonded with a carbon-carbon double bond. They are antimicrobial substances synthesized 
by the plant at the site of infection. Resveratrol and pterostilbene are two structurally similar 
stilbenes that have been recognized for their health-promoting properties.  
Bioavailability: Pterostilbene has similar chemical structure as resveratrol except for its 
two methoxy groups in place of the hydroxyl groups of resveratrol. This structural difference 
makes pterostilbene more bioavailable compared to resveratrol. Low quantities of both stilbenes 
have been detected in foods: resveratrol is found in red wine, grapes, and many of the Vaccinium 
berries, with higher amounts found in cranberries, while pterostilbene has been identified in 
several blueberry species (Rimando et al. 2004; Rodríguez-Bonilla, et al. 2011). 
Bioactivity: Resveratrol is thought to be the active compound that creates the French 
paradox - the observation that the French, despite their generally high-fat diet, have lower rates 
of coronary heart disease. Resveratrol’s anti-aging and antidiabetic mechanisms of action are 
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associated with increased cAMP levels, leading to its proposed potency in preventing obesity and 
elevating glucose tolerance and physical stamina in mice (Park et al., 2012). Both resveratrol and 
pterostilbene have positive implications for cardiovascular health because of their actions as 
proteasome inhibitors, suppressing pro-inflammatory cytokines and iNOS genes in mice 
(Qureshi et al., 2012). Pterostilbene has suppressed colon cancer, cell proliferation, and key 
inflammatory markers in vitro and in vivo (Paul et al., 2010). Moreover, it lowered lipid and 
glucose levels in vivo by activating endogenous peroxisome proliferator-activated receptor-alpha 
(PPAR-a), suggesting it may have potential as an anti-obesity agent (Rimando et al., 2005). 
3.4. Procyanidins and their microbial metabolites. 
Chemistry: Procyanidins are some of the most abundant compounds in tea, apples, and 
berries. They are oligomeric flavanols, mainly dimers or oligomers of catechin and epicatechin 
and their gallic acid esters. The structural units of catechins are linked by a single bond in B-type 
procyanidins and by a double bond in the rare A-type procyanidins (Figure 2.5).  Whereas B-
type procyanidins are present in most berries, the A-type procyanidins are less common, but are 
found in cultivated cranberries and wild lingonberries. Higher molecular weight polymeric 
procyanidins are called condensed tannins.  
Bioavailability:  Polymerization has been shown to greatly impair intestinal absorption of 
proanthocyanidins in vitro and in vivo (Baba et al., 2001; Deprez et al., 2001; Donovan et al., 
2002), but depolymerization could occur during thermal processing, in acidic pH environments, 
and in the presence of oxygen. Monomers are absorbed best, and their specific chemical structure 
also plays a role; epicatechin is absorbed much more efficiently than catechin (Baba et al., 2001) 
but it is almost completely conjugated. In contrast proanthocyanidin dimers A1 and A2 are 
absorbed to a much smaller extent, only 5-10% of absorption of epicatechin, but they are not 
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conjugated or methylated in that process (Appeldoorn et al. 2009; Li et al., 2001; Ou et al. 2012).  
Interestingly, procyanidin A2 standard had higher transport ratio (4.8%) in a Caco-2 cell 
monolayer model than a B-type dimer (3%): the amount of procyanidin A2 dimer after transport 
was about 14 μg/mL which is likely enough to for the inhibition of E. coli adherence attributed to 
cranberry procyanidins (Gupta et al., 2007). In humans, procyanidin B1 was detected in human 
serum after intake of proanthocyanidin-rich grape seed extract (Sano et al., 2003). Recent studies 
suggest possible synergistic interactions of polyphenols as some of these compounds specifically 
modify certain metabolic and transport processes governing bioavailability (Scheepens et al. 
2010). For example, tetrameric procyanidins enhanced absorption of procyanidin B2, but not that 
of A1 using an in situ rat small intestinal perfusion model (Appeldoorn et al., 2009). Still, 
oligomeric procyanidins are poorly absorbed and their low levels in plasma and urine suggests 
that most of them may exert bioactivity along the gastrointestinal tract until they undergo 
conversion to simpler metabolites by the microbiota in the colon (de Llano et al., 2015). Such 
bioavailable metabolites deserve further biological evaluation, some of which was undertaken in 
the present research work.  
Bioactivity: A catechin present in tea and cranberry, (–)-epigallocatechin-3-gallate, is a 
strong inducer of endogenous detoxifying phase II gene expression (Masella et al. 2005). Phase 
II enzymes protect tissues from damaging toxins, and declining levels of these enzymes are 
associated with aging, chronic conditions, and cancer. Glutathione is an endogenous anti-
oxidant, and an enzyme involved in its biosynthesis, glutathione S-transferase Alpha, was 
significantly increased in the lungs of mice given polymeric black tea polyphenols for 30 days 
(Patel & Maru, 2008).  
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The oligomeric proanthocyanidins found in red wine have been correlated with good 
vascular health in the regions of France that produce wines with the highest amounts of these 
compounds (Corder et al., 2006). A-type oligomer proanthocyanidins, which are unique to 
cranberries and lingonberries, act as potent bacterial inhibitors in urinary tract infections (Howell 
et al., 2010; Määttä-Riihinen et al. 2005). Cranberry A-type oligomeric procyanidins were found 
to mitigate bone degradation by decreasing matrix metalloproteinases MMP-2 and MMP-9 and 
also to significantly decrease MMP-1 and MMP-9 at 50 µg/mL in macrophages stimulated by 
lipopolysaccharides (LPS) (La et al 2009; Tanabe et al. 2011). The mechanism behind this 
proteinase inhibition was suggested to occur through reduction of phosphorylation of five 
intracellular kinases, namely JNK2 (Thr183/Tyr185), AKT (Ser473), AKT (Thr308), and MEK1 
(Ser217/Ser221) which were increased in macrophages after LPS stimulation and reduced when 
cells were pretreated with 50 µg/mL cranberry procyanidins. Inhibition of nuclear factor-kappa B 
(NF-κB) was also significant (La et al., 2009). A-type cranberry procyanidins (25 µg/mL) also 
significantly decreased adherence of P. gingivalis to human oral epithelial cells while not 
interfering with the growth of the bacteria. Hindering of bacterial attachment to epithelial cells 
instead of killing the microorganism has been proposed to be a new anti-bacterial mechanism 
which would be unaffected by growing antibiotic resistance (La et al. 2010). 
Polymeric proanthocyanidins, which consist of more than 10 epicatechin or catechin 
monomers. although not efficiently absorbed, may directly affect the intestinal mucosa and 
protect it against oxidative stress and toxins (Williamson & Manach, 2005). The gut microbiota 
can hydrolyze proanthocyanidins, increasing their bioavailability: their catabolites in the colon 
have been shown to result in small phenolic acids that can be absorbed more easily and can 
reduce inflammation. Therefore, proanthocyanidins, when metabolized, may have implications 
41 
for chronic inflammatory or autoimmune diseases (Monagas et al., 2009). Proanthocyanidins in 
apples have a direct effect on carbohydrate fermentation by gut microbiota, inhibiting metabolic 
degradation of short-chain fatty acid production (Bazzocco et al. 2008). When carbohydrate 
fermentation is inhibited in the proximal colon, short-chain fatty acid production may be 
extended to the distal colon, thereby reducing the harmful effects of amino acid catabolites there. 
Polyphenol-rich beverages consumed at meal times have been shown to directly affect starch 
digestion by inhibiting starch-degrading enzymes in the upper gut and, therefore, blunt 
postprandial glucose peaks. Blueberries and cranberries added to whole grain cereal foods, 
therefore, could help regulate spikes in glucose levels and synergistically affect the human gut 
microbiota by modulating both species composition and the profile of metabolites absorbed from 
the colon  (Tuohy et al., 2012). 
Berries consumption has been shown to have beneficial effects on chronic diseases such 
as cancer, diabetes, COPD, and neurodegenerative diseases. There is evidence that berries could 
help activate endogenous detoxifying enzymes, improve gut microflora, and enhance focus, 
memory, and feelings of happiness. Yet, a single berry consist of thousands of phytochemicals 
and research has focused on dereplication strategies for pinpointing quickly and correctly the 
compounds with most bioactivity. The work in the following chapters proposes an improved 
workflow in such nutraceutical investigations by exploring Vaccinium berries for their antiviral, 
anti-inflammatory, and anti-protease potential. Bioactivity, along with absorption and 
metabolism of individual polyphenolic compounds should be accounted for when linking 
potential health-promoting properties of specific compounds with polyphenol-rich foods. 
Furthermore, the content of individual phytochemicals varies depending on the plant species and 
the food processing methods, which need to be considered in dietary intervention studies.   
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Chapter 3: Therapeutic compounds for chronic obstructive pulmonary 
disorder from selected Vaccinium species and other dark colored 
berries  
 
1. Pharmacological potential of berry polyphenols in prevention of COPD 
Chronic obstructive pulmonary disorder (COPD) is a major cause of death worldwide. Its 
primary risk factor is tobacco smoking. Upregulated nuclear factor NF-κB and MAPK/ERK 
pathways in airways of COPD patients (Di Stefano et al., 2002) are increased further by cigarette 
smoke extract (Brown et al., 2009) leading to high levels of inflammatory cytokine IL-8 and 
collagen proteinase MMP-1 in the airway epithelium (Kim et al., 2004; Ordoñez et al., 2000). 
Current corticosteroid therapies do not modulate the underlying inflammation, but only 
temporarily control symptoms (Highland et al., 2003).  
A large epidemiological study, the Morgan study, found an association between dietary 
intake of apple flavonoids and the prevention of diseases, such as asthma and COPD (Tabak et. 
al., 2001). Apple skin is a rich source of oligomeric procyanidins, which have been recognized as 
anti-inflammatory and anti-cancer agents (Ou et al., 2014). Recently, a grape seed procyanidin 
was shown to down-regulate the NF-κB and MAPK/ERK pathways (Zhao et al., 2013). 
Procyanidin-enriched fractions have also been found to inhibit MMP-1 and IL-8 in other disease 
model systems (Bodet et al., 2007; La et al., 2009), but activity reports of individual procyanidin 
compounds in smoke-exposed small airway epithelial cells (SAEC) after cigarette smoke 
exposure (CSE) are lacking.  
Procyanidins differ in their activity although they consist of repeating catechin and 
epicatechin units (Dudek et al., 2017). Foods rich in procyanidins include berries, grape, apple, 
and cocoa powder. Since these foods contain a multitude of procyanidin compounds with similar 
chemical profiles, distinguishing the most active compounds is difficult. The current study 
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proposes an improved natural product discovery workflow implementing less sampling, 
fractionation, and bioactivity by comparing three parallel oligomeric procyanidin fractions, each 
obtained from a Vaccinium berry, commonly consumed in the temperate zone, namely blueberry, 
cranberry, and lingonberry. Furthermore, the study investigates some of the indirect health-
beneficial effects from procyanidins, such as upregulating endogenous antioxidant enzymes 
(Kode et al., 2008; Rahman, 2012), modifying epigenetic factors, or being converted to more 
bioavailable and biologically active microbial metabolites. 
2. Materials and methods  
2.1.Materials and reagents 
Sep-Pak® C18 Vac solid cartridge (20 cc, 5 g sorbent; Waters Corp., Milford, MA) and 
Sephadex LH-20 from Pharmacia Fine Chemicals (Piscataway, NJ) were used for solid phase 
extraction and open column chromatographic separations, respectively. HPLC analysis was 
carried out on a 250 x 4.6 mm, 4 µm Synergi Hydro-RP 80A column, which was purchased from 
Phenomenex (Torrance, CA). HPLC-grade acetonitrile, MeOH and formic acid were purchased 
from Baker (Philipsburg, NJ) and GR grade MeOH, and EtOH, ethyl acetate, and n-butanol from 
VWR Inc. (Bridgeport, PA). Ultrapure water was prepared using a Millipore Milli-RO 12 plus 
system, (Millipore Crop., Bedford, MA, USA). Procyanidin A2 and procyanidin B2 were 
purchased from Alkemist Labs (Costa Mesa, CA, USA) and quercetin 3-β-D-glucoside was 
purchased from Sigma Chemical–Aldrich (St. Louis, MO, USA). Jaboticabin was synthesized 
from commercially available phloroglucinol and 3,4-dihydroxybenzoic acid in nine linear steps 
by our collaborators (Wu et al., 2013). 
2.2.Plant material 
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Cranberry (Vaccinium macrocarpon Ait. var. ‘Early Black’) and blueberry (Vaccinium 
corymbosum cultivar ‘Bluegold’) samples were collected at the end of October 2011 and July 
2011, respectively. These cranberry and blueberry fruits, along with other blueberry cultivars 
such as Bluecrop, Blueray, Legacy, Elliott, and rabbiteye species, Baldwin, were obtained from 
and cultivar identification verified at the Rutgers University Marucci Center, New Jersey. 
Lingonberry (Vaccinium vitis-idaea) grown in Canada was purchased in May 2012 as frozen 
fruit from Scandinavian Butik, Norwalk, CT (http://www.scandinavianbutik.com). A wild 
blueberry species was collected in June 2012 from Storm King mountain, NY, and identified by 
its morphology as Vaccinium pallidum. All fruit was frozen immediately and stored at - 20 °C 
until used. 
2.3.Extraction  
Cranberry, lingonberry, and blueberry frozen fruits (500 g of each) were extracted three 
times with 70% aqueous methanol with ratio of 1:5 (w/v) plant to solvent. Each berry crude 
extract was filtered using Whatman #4 filter paper and concentrated under reduced pressure. 
2.4.Fractionation 
Dried crude cranberry extract (20 g) was dissolved in water and partially purified on 
Diaion HP-20 resin by water to remove sugars and small phenolic acids. The remaining 
desugared fraction (DS) was eluted with methanol and used in bioactivity assays or further 
fractionated on Waters C18 Sep-Pak Vac 20 cc 5 g cartridges according to a method described 
previously (Sun et al. 2006) with slight modifications including using Sephadex LH-20 as the 
second column. Shortly, the Sep-Pak column was conditioned, and each DS extract was passed 
through the cartridge at a flow rate not higher than 5 mL/min. Sugars and phenolic acids were 
further eliminated by elution with 80 mL water (yield: 62.5% of the dry extract). Ethyl acetate 
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(30 mL) eluted catechins, oligomeric procyanidins, and other small phenolic molecules (yield: 
1.34% from dry extract loaded, cranberry) while the polymeric procyanidins (PP) and 
anthocyanins and flavonol glycosides (AF) were eluted with 20 mL of methanol acidified by 
0.1% HCl.  
The ethyl acetate fraction (170 mg) was dissolved in 3.5 mL of 50% aqueous methanol 
and loaded on a 28 x 4 cm Sephadex LH-20 column to clean up oligomeric procyanidins from 
other compounds by a previously described method (Tanabe et al. 2011). The fats and waxes 
retained on the Sep-PAK C18 and Sephadex LH-20 sorbent were discarded. Most of catechin 
monomers and flavonol glycosides were washed by 50% aqueous methanol at a flow rate of 2 
ml/min and the remaining oligomeric procyanidins were eluted with 70% aqueous acetone to 
produce fractions of cranberry, lingonberry, and blueberry enriched in oligomeric procyanidins 
(1C, 1L, and 1B, respectively).  
The remaining compounds from the SPE column were eluted with acidified methanol and 
loaded on Sephadex LH-20 to yield anthocyanins and flavonoid glycosides (2) eluted with 
ethanol, and polymeric procyanidins (3), eluted with acetone for comparative tests in the IL-8 
inhibition assay (Figure 3.1).  
Acetone was removed under reduced pressure and the resulting fractions freeze-dried. 
The absorbance of final fractions was measured by photodiode array detector to verify that the 
peaks with absorption maxima 280 nm and 360 nm were present and not at 450 nm or 520 nm, 
which confirmed the absence of anthocyanins. The presence of procyanidins with A-type 
linkages was confirmed using electrospray ionization (DI/ESI MS) with a method described 
below. All eluates were concentrated to dryness in a rotary evaporator at 25°C. 
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Fig. 3.1 Fractionation scheme yielding three fractions from each desugared extract: (1) enriched 
oligomeric procyanidins, (2) anthocyanins and flavonol glycosides, and (3) polymeric 
procyanidins. Modifications from reported method included the use of Diaion HP-20 and 
Sephadex LH-20 columns (Sun et al., 2006). 
 
2.5.Isolation of A-type procyanidin trimer 
The cranberry oligomeric procyanidin fraction (1C) (60 g) was dissolved in 0.1% aq 
formic acid and loaded on another C18 Sep-Pak Vac 20 cc 5g cartridge. Column was 
equilibrated with 80% Water (0.1% FA) and 20% acetonitrile and after sample was loaded, 
acetonitrile concentration was increased to 30%. The first fraction of 20 mL (10.5 mg d.w.) was 
used in for isolation of the A-type trimer. Semi-preparative Waters HPLC with an Alliance 
separation module unit and PDA detector on a 250 x 10 mm, 4 μm Phenomenex column 
(Torrance, CA, USA) kept at 25 ºC were used to isolate the first eluting, major A-type trimer 
used in the bioactivity assays. The purity of the isolated A-type trimer was 95 % determined by 
analytical HPLC and LC-MS.  
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Fig.3.2 Ion spectrum of the isolated A-type trimer from a) negative and b) positive mode runs, 
showing parent ion masses of 863 and 865, respectively. 
 
2.6.LC-MS and chemometric analysis 
 Preparation of samples for LC-MS analysis.  
Extracts and fractions were brought up to 2 mg/mL using LC/MS grade methanol after 
filtration through a 0.45 μM syringe filter.  
 HPLC-TOFMS conditions  
The analytical HPLC system (Waters Corp., Milford, MA) consisted of a Waters 2695 
Separation Module equipped with a 2996 photodiode-array detector (PDA) and coupled to the 
Waters Empower (version 5.0) for data acquisition and processing. Separation was carried out 
using a 250 × 4.6 mm, 4 μm Synergi Hydro-RP 80A column (Phenomenex, Torrance, CA). 
Fractions were dissolved in LC/MS methanol, filtered through a 0.20 μM syringe filter and 
brought up to final concentration of 2 mg/mL, before injection (5 μL). The flow rate was 
1mL/min and the mobile phase consisted of solvents A (1% aqueous formic acid solution) and B 
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(acetonitrile) as follows: 10% B for 3 min; 12-30 % B from 3–15 min; 30–82 % B from 15 to 25 
min, 82-90 % B from 25-40. The composition was then changed to the initial conditions and 
maintained for 10 min prior to the next injection. The results were monitored using a photodiode 
array (PDA) detector set to record wavelengths from 210 to 600 nm and absorption maxima data 
was used in tentative identification of marker compounds.  
High-resolution electrospray ionization mass spectroscopy (HR-ESI-MS) was performed 
using a Waters LCT Premier XE TOF mass spectrometer (Milford, MA) (LC-MS-TOF) 
equipped with an ESI interface, controlled by Waters MassLynx V4.1 software. Mass spectra 
were acquired in negative mode over the range m/z 100–2000. The capillary voltage was set to 
2700 V and the cone voltage was 20 V. The desolvation and cone gas flow rates were 600 and 20 
L/h, respectively. The desolvation temperature was 400°C, and the source temperature was 
120°C. Negative ESI data for the chemometric analysis were collected using a scan time of 1 s, 
with an interscan time of 0.01 s and a polarity switch time of 0.3 s.  
  MarkerLynx 
Chemometric analysis was performed using Waters MarkerLynx XS software. 
Chromatographic peaks were detected in the negative mode and processed following the 
parameters: 0.5-21.5 min retention time, 100–1200 Da mass range, and mass tolerance of 1 Da. 
Isotopic peaks were excluded from analysis, the noise elimination level was 4.00, the intensity 
threshold (counts) was 100, and retention time window was 0.4 min. The retention time and m/z 
data pair for each peak was organized by ApexPeakTrack. The data matrix was constructed 
setting injected samples as the Y variable and marker metabolites as the X variable. Principle 
component analysis (PCA) and orthogonal partial least-squares discriminatory analysis (OPLS-
DA) on the data matrix were conducted using SIMCA-P+, built in to the MarkerLynx XS 
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platform. Pareto scaling was used, with marker ion intensity normalized to the total spectral 
intensity of the individual sample spectrum, set to 10,000.  
  Support Vector Machine method 
Anaconda 5.0.1 with Python 3.6 version provided the Pandas package and the machine-
learning library Scikit-learn used for ranking of marker compounds analyzed by Support Vector 
Regression (SVR) using linear kernel and weight vectors (McKinney, 2010; Pedregosa et al., 
2011).  
  UPLC-QTOFMS Analysis  
The mass spectra data for identification and quantification of marker compounds were 
recorded using a Xevo G2 QTOF equipped with an ESI source and controlled by MassLynx v4.1 
software. Separation was performed with a 2.1 × 50 mm i.d., 1.7 μm Phenomenex Kinetex C18 
UPLC column coupled to a Phenomenex UPLC C18 SecurityGuard ULTRA cartridge (2.1 mm 
i.d.). The column was maintained at 40 °C. The mobile phase consisted of 0.1% aqueous formic 
acid (A) and 0.1% formic acid in acetonitrile (B). The linear gradient elution was performed as 
follows: 0−0.3 min, 0% B; 0.3−1.5 min, 0−11% B; 1.5−2.5 min, 11−11% B; 2.5−6.0 min, 11-
15% B; 6.0−9.0 min, 15−35% B; 9.0−10.5 min, 35−90% B; 10.5−10.51 min, 90−100% B; 
10.51−11.5 min, 100−100% B; 11.5-11.51 min 100-0% B; 11.51-14.0 min 0-0% B. A flow rate 
of 0.5 mL/min was employed for elution, and 1 μL sample (2 mg/mL) or standard was injected. 
Stock solutions of standards were dissolved in LC/MS methanol and further diluted to obtain six 
concentrations of each standard for quantification based on retention time and parent ion mass 
scan. The MS and MSn data resolution modes of scans were applied. The MSn experiments were 
conducted in the centroid configuration in the negative mode, with a range of m/z 50−1500 Da, 
and survey scan time was 0.5 s, the low energy was set as 6 V, while the high energy was 
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ramped from 10 to 30 V. MS full scanning was conducted in positive ion mode over the range 
m/z 100−2000 Da in two channels, with a scan time of 0.5 s. The capillary voltage was 2500 V 
(negative mode), and 3000 V (positive mode), and the cone voltage was 30 V. Nitrogen gas was 
used both for the nebulizer and in desolvation. The desolvation and cone gas flow rates were 600 
and 50 L/h, respectively. The desolvation temperature was 400 °C, and the source temperature 
was 110 °C. The lock mass solution of leucine enkephalin (1 μg/mL) in acetonitrile/water (1:1) 
containing 0.1% formic acid was utilized as the lock mass at a flow rate of 10 μL/mL, with m/z 
556.2771 for the positive mode and m/z 554.2615 for the negative mode. 
2.7. Cigarette smoke extract (CSE) preparation and human primary cell treatment 
CSE was prepared using a modified protocol as previously described (Laurent et al. 
1983). Briefly, a Barnet vacuum pump operating at constant flow was used to draw the smoke of  
one 3R4F research grade cigarette (University of Kentucky, Lexington, KY) through 25 mL of 
Dulbecco’s phosphate-buffered saline. This solution (100% CSE) was adjusted to pH 7.4, 
filtered, diluted with small airway growth medium to a final concentration of 5%, and added to 
the cells immediately.  
Human small airway epithelial (SAE) cells were cultured according to the supplier’s 
instructions (Lonza, Walkersville, MD), and maintained in a controlled atmosphere of air 5% 
CO2 at 37
o C. Cell populations used for treatment were 80% confluent, between passages 2–5, 
and serum starved overnight. Cell viability was assessed following CSE or compound exposure 
using the AlamarBlue kit (Invitrogen, Carlsbad, CA) according to manufacturer’s specifications. 
2.8. IL-8 immunoassay 
Cells were incubated with or without 5% CSE and treated with fractions or pure 
compounds 20 min after CSE exposure. Supernatants from cells were collected after 24 h, and 
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centrifuged (1,000 × g for 15 min) to remove particulates. Protein concentration was evaluated by 
bicinchoninic acid assay (BCA Protein Assay, Pierce) and supernatants were diluted to equalize 
the amount of protein in each sample. Levels of IL-8 were measured by ELISA (R&D Systems 
Inc., Minneapolis, MN).  
2.9. mRNA expression  
The cells were cultured and treated as described above. After 24 h of treatment, total 
RNA from the human SAE cells was isolated (RNeasy kit, Qiagen, Valencia, CA) and converted 
into cDNA (high capacity cDNA kit, Thermo Fisher Scientific, Canada). Relative expression of 
MMP-1 was measured using real-time quantitative PCR and Taqman probes (MMP-1 
Hs00899658_m1) with GAPDH as an endogenous control (Thermo Fisher Scientific, Canada). 
2.10. Statistics 
Bioassay data are recorded as means ± SD, from three independent experiments. One-way 
analysis of variance (ANOVA) was performed with significant differences between means 
determined by the Student’s t-test using Prism V5.00 (GraphPad Software, CA, USA). The level 
of significance was set at P < 0.05.  
3. Results and discussion 
3.1.Extraction and fractionation 
Methanol has been shown to be more efficient at extracting anthocyanins than ethanol or 
water, and acid was not added in order to preserve the native form of anthocyanins and acylated 
anthocyanins (Castaneda-Ovando et al., 2009). Seventy percent methanol was used to obtain 70, 
90, and 110 (mg/g of fresh fruit) crude extraction yield for cranberry, lingonberry, and blueberry, 
respectively. The crude extracts were partially purified on Diaion HP-20 resin by water to 
remove sugars and small phenolic acids. The remaining desugared fraction (DS) from each 
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species was eluted with methanol and yielded approximately 40% of the crude extract weight. 
The employed fractionation scheme utilized one major partition step through an SPE column 
with two clean-up steps before and after the SPE column to obtain the enriched oligomeric 
procyanidin fraction 1, with yields 13%, 28%, and 21% w/w of desugared cranberry, 
lingonberry, and blueberry extracts, respectively.     
3.2.Initial bioactivity screening  
Desugared methanol extracts (DS) at 100 μg/mL and oligomeric procyanidin fractions 
(100 μg/mL) of the three Vaccinium berries (1C,1L, and 1B) were tested for their IL-8 inhibitory 
activity on human SAE cells exposed to CSE.  
Fig. 3.3 Berry fractions anti-inflammatory activity: a) Separation of oligomeric procyanidin 
enriched fraction from cranberry (C), lingonberry (L), and blueberry (B) b) Interleukin 8 (IL-8) 
inhibition by different fractions (100 μg/mL) in SAE cells not treated (open bars) and treated 
(bold bars) to cigarette smoke extract (CSE). Results are expressed as the mean ± SD from three 
independent experiments (n = 3). Letter d stands for desugared extract, and number 1 denotes 
oligomeric procyanidin enriched fraction from the respective berry; * indicates significant 
difference from CSE-treated vehicle (grey bar) *P < 0.05, **P < 0.001, by Student’s t-test 
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comparison among the desugared extracts ranked cranberry as the most active from the three 
Vaccinium berries, followed by lingonberry and blueberry. Similar activity trend was observed 
for oligomeric procyanidin fractions, with 1C inhibiting IL-8 the most (Figure 3.3).  
Blueberry anthocyanin-enriched fraction 2B was included in the experiment because a 
major blueberry anthocyanin, delphinidin-3-glucoside was found to inhibit IL-8 levels in the 
same model system (Reynertson et al., 2006). However, 2B had slightly weaker IL-8 inhibitory 
capacity compared to less studied oligomeric procyanidin fractions 1C and 1L (Figure 3.4). The 
rest of the compounds from the fractionation of blueberry extract eluted in fraction 3B consisted 
of polymeric procyanidins. 3B was also screened for IL-8 inhibition to capture the response from 
all fractions making up the blueberry desugared extract, but it had the weakest IL-8 inhibition of 
all tested fractions. Still, polymeric procyanidins could exert an indirect anti-inflammatory effect 
as they improve absorption rates of smaller procyanidins (Appeldoorn, et al. 2009) and may get 
degraded by the microbiome to more bioavailable and bioactive compounds. 
Fig. 3.4 Inhibition of Interleukin 8 (IL-8) by 
different blueberry fractions (100 μg/mL) in 
SAE cells not treated (open bars) and treated 
(bold bars) with CSE. Results are expressed 
as the mean ± SD from three independent 
experiments with two replicates each (n = 4-
6). Letters denote berry species: C - 
cranberry, L - lingonberry, B – blueberry; 
numbers denote fraction from the respective 
berry: 1 - oligomeric procyanidins, 2 – 
anthocyanins and flavanol glycosides, and 3 
– polymeric procyanidins. * indicates 
significant difference from CSE-treated control (grey bar) *P < 0.005; **P < 0.0001 by Student’s 
t-test 
 
3.3. An improved approach for chemometric-driven discovery of bioactive phytochemicals  
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Bioactivity studies combined with chemometric methods have been used to predict 
bioactive compounds from both multiple cultivar extracts and among many fractions within one 
extract (Fujimura et al., 2011; Kulakowski et al., 2014). Yet, these samples vary a lot in their 
chemical profiles leading to a larger pool of total compounds, inclusive of the active one(s) (1.5 
a). Figure 3.5 shows schematically the rationale behind how a decreased variance among 
samples results in a smaller number of total differentiating markers.  
  
Fig. 3.5 Venn diagrams comparing two samples with increasing chemical profile similarity, 
pertaining to the total number of markers with Higher Relative Abundance (HRA) between them. 
The total number of markers is represented by the area of the circle. Capital letters refer to 
sample 1 and small letters, to sample 2. Unique compounds (U/u) for each sample are to the 
sides in the non-overlap regions, while shared compounds (S/s) are in the overlap region. 
Assuming compounds are either more or less concentrated in each sample, the probability of 
shared compounds with HRA in each sample is 50%. Dashed line separates the shared 
compounds to shared ones with HRA and such with lower relative abundance (LRA) for each 
sample. (e.g., LRA compounds for sample 1, represented in grey are the HRA markers of sample 
2. The total number of HRA compounds for sample 1 is the sum of its unique markers (U) plus 
half of its shared compounds (S) marked with diagonal lines. The area marked by diagonal lines 
decreases from a) to c) because as similarity between two samples increases, the total number of 
HRA compounds (unique and shared, but more abundant compounds) decreases. 
In the current proposed strategy, decreased sample variance is achieved by starting with 
closely related material – species within the same genus (cultivars within one species, in Chapter 
4). Furthermore, the number of unique compounds (U/u) is reduced by focusing on 
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phytochemical comparisons of fractions enriched in the same class of compounds across the 
three cultivars. 
A smaller number of unique markers that differentiates the samples by their respective 
concentration is important especially when the sample size is small compared to the number of 
metabolites. With fewer total markers (due to fewer unique markers), the probability that each of 
the identified compounds is a bioactive one increases, with most chemical differences resulting 
primarily from varying concentrations of a specific compound, instead of its presence or absence 
in the samples.  
Robustness of the approach would increase if there was a significant difference between 
activity of samples (1C vs 1L). Yet, in this study, there was a compound that had the opposite of 
the desired activity but was more abundant in the more active fraction, so the overall activity of 
cranberry fraction 1C was dampened by the greater abundance of procyanidin A2, which was 
found to induce inflammation (Figure 3.6 b). A study on tea cultivars also found the relative 
level of a compound to be strongly inversely correlated with bioactivity, naming the marker a 
negative regulator of bioactivity (Fujimura et al., 2011). To discount the effect of this negative 
regulator, the compound could be either isolated (which is labor intensive) or added in order to 
achieve the same concentration (and same effect) across both samples. Once its additive effect 
cancels out, total activity differences among samples will result from other compounds. Finally, 
although peak intensities are normalized before analysis, any difference in instrument sensitivity 
favoring one class of compounds over another would be negated by comparisons across samples 
enriched in one polyphenol class. 
 Transitioning from binary OPLS-DA to multiclass comparison accounting for 
different degrees of activity 
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Metabolomic studies widely utilize classification techniques, such as orthogonal partial 
least squares/projections to latent structures (PLS-DA) because there are far more metabolites 
(variables) than replicates (observations). One way to decrease these variables is through 
selecting similar samples to compare (Figure 3.5). Supervised orthogonal PLS-DA (OPLS-DA) 
analyzes the variation of each PLS component removing systemic variation (middle of S-plot) 
and improves interpretation. Yet, in these binary statistical approaches the samples need to be 
classified as either active or inactive, not allowing for assignment of intermediate levels of 
activity. A binary comparison prioritizes markers that explain variability between the samples 
based on marker concentration differential. Therefore, top-ranked markers will be those more 
abundant in the active samples and having the largest concentration differential between the 
samples. In the proposed method, top-ranked markers have relative concentration corresponding 
to the relative activity of the samples: high marker concentration in the most active sample, 
lower concentration in the less active sample, and lowest concentration in the least active sample. 
This investigation devised a simple approach of overlaying two binary comparisons obtained 
from user friendly, built in software, the OPLS-DA statistical method and comprising the top-
ranked markers list from the overlap (Figure 3.6). Combinations 1 and 2 are inherently binary 
comparisons, where samples could be classified as active or inactive. Yet, combination 3 overlap 
results could not be obtained with one step comparison. It includes two steps: one vs. the rest 
comparison (C, L > B) and one vs. one (C > L) comparisons. The first 50 markers from the first 
comparisons are matched to the first 25 markers from the second comparison, and only the 
overlapping markers are selected in the final top-ranked marker list. Thus, markers with medium 
relative concentration in 1L are upgraded, corresponding to the medium activity of 1L. Other 
markers the relative concentration of which doesn’t follow the samples’ activity trend are 
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discarded. The proposed strategy assumes a dose-response relationship for the active compound 
in the sample and helps obtain a tailored top-ranked marker list corresponding to the samples’ 
activity trend. 
 
Fig. 3.6 Schematic representation of binary and combination of OPLS-DAs selecting top-ranked 
markers based on their highest concentration differential in the samples. Bars represent the 
relative concentration of the top-ranked markers in the respective sample: cranberry (C) – black 
bar, lingonberry (L) – grey bar, blueberry (B) – white bar. Binary combinations 1 and 2 separate 
samples in two groups (active vs inactive). Combination 3 overlaps markers from two 
comparisons (i and ii), leading to top-ranked markers that are most concentrated in cranberry, 
less, in lingonberry and least in blueberry, corresponding to respective activity of the samples. 
Initially we used combination 2, as there was not much difference between 1C and 1L 
samples, which were classified as active and compared against 1B (Figure 3.3). Yet, one of the 
high ranked markers (A2) turned out to have proinflammatory instead of anti-inflammatory 
activity (a negative regulator) (Figure 3.12 a). A2 was much more abundant in 1C than in 1L, so 
it reduces the overall anti-inflammatory activity of 1C, making it not statistically different from 
the activity of 1L. Therefore, if A2 is removed or its effect, disregarded, fraction 1C would have 
higher activity than 1L, matching to the proposed analysis in combination 3 (Figure 3.6).   
Combination 1: Combination 2: Combination 3:
15
ii: C > L
overlapoverlap
i: C > L 
ii: C > B
overlap
i: C > B 
ii: L > B
iii: C > L, B iii: C, L > B 
i: C, L > B 
iii: C > L >> B 
BINARY BINARY MULTICLASS
50
25
12
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Combination 3, aligning two OPLS-DA comparisons yielded 12 top-ranked markers 
(Table 3.1). This improved combination process had two comparisons: (i) 1C and 1L were 
compared with least active sample 1B (one vs. the rest); and (ii) the more active samples were 
compared against each other 1C verses 1L (one vs. one). The markers from the latter comparison 
(ii) that did not also appear in the first 50 markers from comparison (i), were excluded because 
they represented compounds with relative concentration higher in 1L versus the most active, 1C, 
while still having the least concentration in 1B. The overlapping markers were kept in the list as 
they met both conditions, namely, they had lower relative abundance in 1L vs. 1C, and the 
lowest in 1B vs. 1L and 1C. These remaining markers were listed in decreasing order of their 
respective variable importance to the projection (VIP) scores from the (ii) analysis (Table 3.1). 
Eleven markers were identified, and three of them were tested in our anti-inflammatory assay 
and quantified (Table 3.2). Finally, an upgrade or downgrade of each marker is noted between 
the binary comparison and combination 3.  
As shown in Table 3.2, the not active dimer A2 (15.92_575.1661) decreased in rank in 
Combination 3. Two of the tested (active) compounds did not appear in the binary analysis first 
12 top-ranked markers. Another marker that appeared in Combination 3 and was missing from 
the binary analysis (ranked lower than the first 12 markers) was tentatively identified as an 
isomer of jaboticabin. Previous studies in our laboratory had identified jaboticabin for the first 
time and had shown its ability to inhibit IL-8 (Reynertson et al., 2006). Its tentatively identified 
isomer (16.66_333.0846), which appeared in the top-ranked list may also hold similar anti-
inflammatory activity, but it was not tested in the current project.  
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Table 3. 1 Comparison of top-ranked markers and their relative abundance trend from OPLS-DA 
binary and Combination 3 analysis, and linear SVR from the three oligomeric procyanidin 
fractions (Fraction 1) of each respective Vaccinium berry: C - cranberry; L – lingonberry; B – 
blueberry. Binary comparison top markers from grouped active vs. non-active samples are shown 
with respective VIP scores in decreasing order. Combination 3 overlapping markers between two 
binary OPLS-DA comparisons, ranked by decreasing VIP scores from the second comparison (C 
> L). SVR top ranked markers distinguishing C from the rest. Markers in shaded lines were 
tested individually in the anti-inflammatory assay. An example of abundance trend comparison 
could be found in Appendix C. 
3.4.Metabolic profiling and chemometric analysis  
A common LC-TOF-MS method was developed for all samples to allow for the unification 
of marker variables from the retention time and ion mass (RT_m/z). Total ion chromatograms 
(TIC) of the three Vaccinium oligomeric procyanidin fractions were analyzed with an untargeted 
multivariate statistical method, PCA, using retention time, exact mass, and ion intensity as 
variables from three replicate injections. An analysis of all three fractions 1C, 1L, and 1B, 
separated the most active cranberry sample into a distinct PCA cluster from the less active 
lingonberry and blueberry fractions (Figure 3.7b). 
1 15.92_575.1661, 5.5 C > L > B 19.21_447.1408 2.0        3.8    C > L > B 15.92_575.1661 C > L > B
2 13.92_575.1566, 3.3  L > C > B 15.92_575.1661 5.5        2.9    C > L > B 17.02_479.1191 C=L > B
3 17.02_479.1191, 3.1  L > C > B 16.66_333.0946 1.0        2.9    C > L > B 14.83_449.0902 C > B > L
4 13.83_863.5068, 3.0  L > C > B 20.88_609.2010 1.3        2.5    C > L > B 14.83_449.1257 C > B = L = 0
5 13.86_863.2806, 3.0 C = L > B 17.18_477.1218 1.4        2.5    C>>L=B=0 13.48_479.1228 C > B > L
6 15.92_423.1184, 2.9 C > L > B 16.37_863.2813 2.2        2.4    C > L > B 19.21_447.1408 C > L > B
7 13.55_319.0740, 2.7  L > C > B 20.01_445.1673 1.1        2.2    C>>L=B=0 9.99_289.0956 C > L > B
8 15.90_621.1969, 2.4 C > L > B 8.42_577.1994 1.3        1.9    C > L > B 16.37_863.2813 C > L > B
9 20.02_591.1750, 2.4 L > C = B = 0 19.57_477.1587 1.8        1.8    C > L > B 16.66_333.0946 C > L > B
10 9.99_289.0956, 2.3 C > L > B 9.99_289.0956 2.3        1.8    C > L > B 15.92_423.1184 C > L > B
11 16.37_863.2813, 2.2 C > L > B 11.50_863.2893 1.8        1.7    C > L > B 13.83_863.5068 L > C > B
12 19.21_447.1408, 2.0 C > L > B 16.04_711.2219 1.4        1.6    C > L > B 13.86_863.2806 C = L > B
 Fraction 1 
Combination 3
 marker             
(RT_m/z, VIP) 
 abundance 
trend 
 marker 
(RT_m/z) 
 C,L > B 
(VIP) 
 C > L 
(VIP) 
 abundance 
trend 
 marker 
(RT_m/z) 
 abundance 
trend 
 Rank 
Binary SVR (linear)
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Fig. 3.7 Phytochemical comparison among oligomeric procyanidin fractions from 
Vaccinium berries: a) overlaid chromatograms of fractions 1C (green) and 1L (red) at 360 nm to 
detect flavanol glucosides and at 280 nm to detect procyanidins: difficult to discern the most 
differentiating markers, by area under the peaks. b) Chemometric analysis combining mass 
spectrum data and anti-inflammatory activity: top - PCA scores plot shows the two comparisons 
labeled with solid or dashed outline, where the larger shape designates the sample(s) which 
is(are) considered active: Lingonberry 1L was considered both active (larger ellipse) grouped 
with 1C vs 1B, and inactive (smaller circle) when individually compared to 1C. bottom - a scatter 
plot (S-plot) of OPLS-DA comparing compound abundance in the more active 1C vs less active 
1L fraction. Covariance and correlation is plotted on the x- and y-axis, respectively. 
Marker ions in the extreme lower left quadrant of the S-plot had higher abundance in the 
most active 1C and contributed most to differentiating 1C from 1L. Eleven overlapping markers 
from Combination 3 with the highest variable importance to the projection (VIP) scores were 
identified and three of them were tested in vitro for their bioactivities, relevant in the treatment 
of COPD (Table 3.1). 
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3.5. Ranking of marker compounds by SVM 
PLS-DA methods are some of the most popular tools in metabolomics because they are 
widely available in statistical software packages and can analyze highly collinear and noisy data. 
Recently, alternative supervised learning methods, such as Support Vector Machines (SVM) and 
Random Forests (RF) have been used in metabolomic studies (Cappellin et al., 2013; Gromski et 
al., 2015; Trainor et al., 2017). SVM constructs a hyper-plane or set of hyper-planes in a high 
dimensional space, where a good separation is achieved by the hyper-plane that has the largest 
distance to the nearest training data points of any class (Pedregosa et al., 2011).  
The current project explored SVM with linear regression (SVR) and weight attributes to rank 
the markers. To simplify the model, a linear relationship was assumed between the relative 
concentration (intensity) of the most active markers and overall activity of the sample. The data 
file with the marker variables and their respective intensities was obtained from MarkerLynx 
after having applied the same MarkerLynx method as for the OPLS-DA analysis. Some of the 
twelve top ranked markers by SVR had very similar retention times and masses. Most of these 
redundant markers were filtered out by specified mass and retention time windows found in the 
MarkerLynx method section. Different parameter effects on the model and markers have been 
recently reviewed (Peters et al., 2009). A larger sample size may help discard some of the 
redundant markers. Treatment with CSE and fractions 1C, 1L, and 1B inhibited IL-8 levels 
compared with CSE-treatment only by 54%, 40%. 29%, respectively. These percentages were 
normalized to the highest one to represent the relevant activity of the samples among each other 
and were used to assign the linear SVR weights, namely, 0.99 (C), 0.74 (L), and 0.54 (B). The 
weight vector in linear SVM methods and other methods for variable and feature selection have 
been recently reviewed (Guyon & Elisseeff, 2003; Saeys et al., 2007).  
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 The SVR analysis ranked first the not active dimer A2 (15.92_575.1661) and included 
the marker tentatively identified as a jaboticabin isomer (16.66_333.0846) in the top twelve 
ranked markers. Compared with the proposed Combination 3, SVR ranked procyanidin dimer B2 
and the tested A-type trimer much lower, 20th and 21st, respectively (Table 3.1). The current 
preliminary investigation of SVR does not provide a conclusion on its superiority as the activity 
of its top ranked markers is unknown. It provides an alternative approach to built-in OPLS-DA 
methods, useful when analyzing more than three groups of samples. Non-linear SVM models 
could be explored to study synergistic or antagonistic effects among the compounds.  
3.6.Identification of cranberry markers 
The first 25 top-ranked markers differentiating 1C from 1L (Figure 3.7b) were 
overlapped with the top 50 markers from comparison of 1C and 1L versus 1B to yield eleven 
common markers from both comparisons. These potentially active compounds were tentatively 
identified using UV/Vis absorbance spectra, exact parent ion mass and characteristic 
fragmentation pattern from the high collision energy function of MSn runs. Available standards 
allowed absolute identification of some of the markers and quantitation displayed in Table 3.2.  
An ethanol clean-up step from Sephadex column removed the majority of flavonoids, yet 
some of them remained and eluted together with the procyanidins in the OPAC fraction. Marker 
compounds 1, 5, and 9 were identified as flavonoid derivatives based on comparison with 
reported elution order, UV-Vis, and MS characteristics data, and they have been found to 
distinguish cranberries from lingonberries (Mikulic-Petkovsek et al., 2012; Vvedenskaya et al., 
2004). Quercetin is widely reported as an inhibitor of IL-8 in lung disease (Ganesan et al., 2013) 
and its derivatives may have similar anti-inflammatory activity.  
  
6
3
 
Table 3.2 Identification of marker compounds from active fraction 1C. The markers tested in the biological assays are highlighted in 
grey. 
 
overlaping 
markers               
#
RT_m/z            
(HPLC-TOFMS)
RT                       
(UPLC-QTOFMS)
parent ion                            
[M-H]
-
(MF, ppm) 
fragment ion 
UV data 
(λmax) 
tentative ID
1            19.21_447.1408 5.89
447.146 [M-H]
-      
(C21H20O11, -0.7)
895.191, 301.0330 270, 352 methoxyquercetin-pentoside
2            15.92_575.1661 4.53
575.1677 [M-H]
-      
(C30H24O12, 0.3)
423.0708, 289.0708 277 procyanidin dimer A2
3            16.66_333.0946 5.02
333.0995 [M-H]
-      
(C16H14O8, -3.6)
271.02, 165.02 256, 353 jaboticabin isomer
4            20.88_609.2010 7.78
609.125 [M-H]
-      
(C30H26O14, 1)
463.0858, 301.0334 270 prodelphinidin B4
5            17.18_477.1218 4.12
477.1049 [M-H]
-      
(C22H22O12, 3.4)
955.2091, 315.0499  265, 353
isorhamnetin 3-O -galactoside 
(isomer)
6            16.37_863.2813 4.81
863.1823 [M-H]
-      
(C45H36O18, 1.2)
575.12, 711.12 269
procyanidin A-type trimer 
(isomer)
7            20.01_445.1673 7.70
445.1673 [M-H]
-      
(C22H22O10, -2)
301.034, 179.03 275 biochanin 7-O -glucoside
8            8.42_577.1994 2.17
577.2048 [M-H]
-      
(C30H26O12, 1.9)
1155.2802, 289.0708 278 procyanidin dimer B2
9            19.57_477.1587 5.96
477.1130 [M-H]
-      
(C22H22O12, -1.3)
955.2101, 315.05  265, 353
isorhamnetin 3-O-galactoside 
(isomer)
10          9.99_289.0956 2.39
289.0706 [M-H]
-          
(C15H14O6, -2.1)
579.1508, 291.0878 280 epicathechin
11          11.50_863.2893 2.55
863.1826 [M-H]
-      
(C45H36O18, 0.3)
575.11, 711.13 269
procyanidin A-type trimer 
(isomer)
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Absolute quantification was performed with the available standards of the compounds, 
further tested in the bioassays. Procyanidin oligomers with a degree of polymerization higher 
than two could be underestimated if a dimer is used for its calibration curve, as the instrumental 
setup has lower sensitivity of compounds with higher molecular masses (Krueger et al., 2013).  
Therefore, the isolated A-type trimer was used to generate a standard curve and quantify its 
amount in fraction 1C. The tested A-type trimer (RT = 2.55min) was found to be the most 
abundant of the three compounds of interest at 154.74 mg/g of dry 1C. Concentrations of 
procyanidins A2 and B2 were determined to be 43.52 and 7.07 mg/g of dry 1C, respectively. 
Fig. 3.8 Chemical structures of compounds with proposed activity from Table 3.2  
*proposed marker compound was an isomer of jaboticabin eluting at 5.0 min.  
*
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 Identification and quantification of jaboticabin in Vaccinium species 
An isomer of jaboticabin was identified as one of the marker compounds in the 1C fraction from 
the overlapping markers between the two OPLS-DA comparisons. Jaboticabin belongs to a 
polyphenol class of compounds called depsides, which are composed of two or more monocyclic 
aromatic units linked by an ester bond. Depsides are often found in lichens, but they have also 
been found in some species of the Ericaceae and Myrtaceae plant families. Previous studies in 
our laboratory have characterized jaboticabin for the first time while researching the fruits of 
Myrciaria cauliflora.  Jaboticabin exerted inhibitory activity on both IL-8 levels and MMP-1 
expression in CSE-induced SAE cells, suggesting its potential for COPD treatment (Reynertson 
et al., 2006). Jaboticabin has been previously reported in cranberry (Turner et al., 2007) and co-
injection of synthetic jaboticabin obtained from our collaborators (Wu et al., 2013) revealed 
detectable quantities of the standard in the cranberry 1C fraction. However, the retention time of 
the marker compound was earlier than the jaboticabin standard, although it had the same 
molecular ion m/z 333.09 as jaboticabin (Fig. 3.9 bottom). The marker compound also had the 
same fragments as jaboticabin, m/z 183.02 and m/z 165.02, which led to its tentative 
identification as a jaboticabin isomer. Lingonberry fraction (1L) had an even greater amount of 
jaboticabin than the cranberry fraction (1C) and to our knowledge, this is the first report of 
jaboticabin in lingonberry (Figure 3.9).  
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Fig. 3.9 Tentative identification of a jaboticabin isomer in 1C based on a) different retention 
time in chromatogram scan for parent ion 333.09, and b) similar parent ion and fragmentation 
pattern in high energy scan (common fragments 165, 301, 183), compared to jaboticabin 
synthetic standard.  
 
The availability of a synthetic jaboticabin standard allowed for an absolute quantification 
of jaboticabin in the cranberry procyanidin fraction 1C by a calibration curve. The quantity of 
jaboticabin (RT=5.44min) and its isomer (RT= 5.09) was determined to be 1.34 and 1.49 mg/g of 
dry 1C, respectively.    
Additional Vaccinium species (Figure 3.10) were analyzed by the same chromatographic 
method, which led to the identification of jaboticabin and its isomer for the first time in all of the 
tested species and cultivars, besides jaboticabin previously reported occurrence in cranberry 
(Turner et al., 2007).  
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Fig. 3.10 Jaboticabin occurrence and relative abundance in desugared extracts of Vaccinium 
berries. qTof extracted ion chromatograms with linked vertical aces for jaboticabin parent ion 
with mass 333.06 of a) different Vaccinium species and b) cultivars of the highbush blueberry 
 
From the comparison among the desugared extracts in Figure 3.10, the lingonberry (V. 
vitis-idaea), wild blueberry species (V. pallidum), and Bluecrop cultivar from the highbush 
blueberry (V. corymbosum) had some of the largest jaboticabin quantities relative to the rest of 
the samples (later eluting peak, at RT=5.44 min). The cranberry and lowbush blueberry 
desugared extracts contained larger proportion of the isomer verses the available standard of 
jaboticabin. 
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 Identification of oligomeric procyanidin markers 
Standards of B2 and A2 were obtained and co-injected to confirm marker compounds h 
and o. Marker m showed characteristic molecular ion of 863.2917 [M-H]- of procyanidin trimer 
with one A-type bond. There were four major peaks with the same molecular ion, with higher 
abundance in cranberry OPAC fraction. Two of these were in the top eleven ranked markers and 
the one with smaller retention time was isolated as it may be more water-soluble and could have 
better bioavailability (Figure 3.10). MSn fragments m/z 411 and m/z 573 were characteristic for 
an A-type trimer with three epicatechin units (Lin et al., 2014). The other A-type trimers should 
be investigated further, as research suggests that slight structural differences among them could 
have great biological significance (Dudek et al., 2017). Here, B2, A2, and TA were evaluated for 
their potential to prevent and treat COPD in our in vitro CSE-induced cell model.  
 
Fig. 3.11 Tentative identification of A-type trimers. Selected ion chromatograms of mass scan at 
863.18 m/z in the cranberry procyanidin fraction (top), and the isolated trimer (bottom), which is 
the first major eluting isomer. 
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3.7.IL-8 and MMP-1 inhibitory activity of the oligomeric procyanidins  
Ample literature is available on anti-inflammatory activity of procyanidin enriched 
fractions (Chapter 2), but only a few studies have focused on activity from individual compounds 
within that class (Dudek et al., 2017). Procyanidin B2 has been shown to inhibit IL-8 in immune-
relevant human cell lines induced with specific stimuli such as TNF-a, TPA/Ionomycin or 
lipopolysaccharides (Jung et al., 2009). The current research investigates the effects of three 
individual oligomeric procyanidins on smoke-exposed SAE cells comparing their anti-
inflammatory potential and ability to downregulate protease expression, relevant for COPD 
pathogenesis.   
Fig. 3.12 Oligomeric 
procyanidins counter cigarette 
smoke extract (CSE) - induced 
modifications: SAE cells were 
not treated (open bars) or 
treated (bold bars) with CSE. 
Response was measured of a) 
IL-8 levels and b) relative 
MMP-1 expression after 
oligomeric compounds (50 μM) 
were added or not (control). 
Results are expressed as the 
mean ± SD from three 
independent experiments (n = 
3). B2 – procyanidin dimer B2, 
A2 – procyanidin dimer A2, 
and TA- trimer with one A-type 
bond;  
* indicates significant 
difference from CSE-induced 
vehicle (grey bar), # indicates 
significant difference from non-
induced vehicle control (first 
open bar) *#P < 0.05 by 
Student’s t-test. 
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CSE-treatment of control SAE cells more than doubled the amount of IL-8 (Figure 3.12). 
At 50 μM, the most active marker was procyanidin B2, followed by TA, both significantly 
decreasing the concentration of IL-8 in CSE-treated SAE cells. In untreated cells, B2 and TA did 
not change the basal production of IL-8. Interestingly, A2 significantly increased IL-8 levels in 
both non-treated and CSE-treated cells compared to non-treated control (Figure 3.12).  
Previous reports have also shown cranberry fraction with A-type procyanidins to increase 
IL-8 levels in osteoclastic cells in relation to periodontal disease, while decreasing matrix 
metalloproteinases MMP-2 and MMP-9 (Tanabe et al., 2011), which could have resulted from 
abundance of inflammatory procyanidin A2. Another report, showed dimer A2 differed 
significantly in activity from a procyanidins A1 and an A-type trimer with catechin terminal unit, 
relative to their effect on dentin elasticity and collagen biodegradation (Nam et al., 2015). An A-
type trimer, also having catechin as its terminal unit was found to be anti-inflammatory in LSP-
stimulated macrophages (Dudek et al., 2017). The other A-type trimer from our marker list 
deserves further evaluation in COPD experimental models as an anti-inflammatory and collagen 
protective agent. 
We evaluated the effect of procyanidins B2, A2, and TA on human collagenase MMP-1 
in our SAE cell model induced by CSE. Control SAE cells after CSE treatment showed two-fold 
increase in MMP-1 expression levels (Figure 3.12). Two procyanidin compounds (50 μM) 
significantly decreased CSE-induced MMP-1 expression with the greatest inhibition detected for 
B2 and lower activity for timer A-type. No significant difference of MMP-1 expression levels 
was observed in the untreated cells after the application of the procyanidin compounds. A lower 
dose of the compounds at 10 μM exerted the same activity trend albeit at weaker inhibition levels 
(data not shown). 
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Previously, our laboratory had shown the ability of ethyl acetate fractions from Costa 
Rican guava to attenuate CSE-induced IL-8 levels and MMP-1 expression in SAE cells (Flores et 
al., 2013). In this research, the ethyl acetate fraction contained most of the A-type oligomeric 
procyanidins from the cranberry and lingonberry fruits. The A-type oligomeric procyanidin 
fraction from cranberry significantly decreased MMPs 1 and 9 at 50 µg/mL in LPS-stimulated 
macrophages (La et al 2009) and inhibited MMPs 2 and 9 activity in human prostate cancer cells 
by affecting either the phosphorylation status and/or the expression of MAP kinase, PI-3 kinase, 
NF-κB, and AP-1 pathway proteins (Déziel et al., 2010). The present research shows for the first 
time the potential of the individual oligomeric procyanidins B2, A2, and TA from cranberry to 
inhibit MMP-1 expression in CSE-induced SAE cells. 
3.8.Antioxidant enzyme expression levels modified by oligomeric procyanidins 
A variety of pro-oxidant factors target the lungs under normal conditions, but tobacco 
smoke amplifies the oxidant burden resulting in increased levels of the major cellular thiol 
antioxidant and redox recycler, glutathione (GSH) in smokers and patients with stable COPD. In 
contrast, GSH levels are reduced during COPD exacerbations (Drost et al., 2005). Direct 
administration of GSH has proven unsuccessful because of bronchoconstriction and problems 
with bioavailability and formation of toxic products (Rahman, 2008). De novo GSH synthesis is 
controlled by the rate-limiting enzyme glutamylcysteine ligase (GCL), also found to be 
upregulated in healthy smokers compared to non-smokers. Its regulatory subunit (GCLM) varied 
considerably between smokers (Hackett et al., 2003), and is also suggested to be associated with 
aging (Liu, 2002), which is relevant for COPD patients who are usually smokers older than 65 
years. A number of natural antioxidant compounds have been reviewed for their involvement in 
mechanisms related to glutathione and glutathione-related enzymes (Masella et al., 2005).  
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Fig. 3.13 Glutathione enzyme GCLM 
expression after treatment with 
procyanidins: GCLM relative mRNA 
levels after SAE cells not treated (open 
bars) or treated (bold bars) with CSE 
after oligomeric compounds (50 μM) 
were added or not (control). B2 – 
procyanidin dimer B2, A2 – procyanidin 
dimer A2 and TA- trimer with one A-type 
bond; Data was obtained from three 
independent cell experiments. 
 
 
 
 
The expression levels of GCLM were assayed after application of smoke and/or procyanidin 
oligomers. No statistical significance was observed among treatments after the experiment was 
repeated three times. Numerically, smoke exposure leading to increased oxidative stress seemed 
to upregulate anti-oxidant GCLM expression in the healthy SAE cells, as expected. Application 
of procyanidin dimer B2 led to no noticeable change of GCLM expression in both CSE-treated 
and non-treated cells, implying a different mechanism of action of the compound. The largest 
numerical downregulation of GCLM expression was observed after application of the A-type 
trimer. In light of these findings, future studies should focus on the effect of procyanidins on 
modifying the expression of GCLM in diseased cells from COPD patients. A number of genes 
with different expression levels in healthy verses COPD human bronchial epithelial cells 
repeatedly exposed to air pollution could guide further investigation of the potential effects of 
procyanidins (Leclercq et al., 2016).   
3.9.Procyanidin B2 epigenetic effect 
Only a small portion of smokers develop COPD, so there might be host-specific factors 
influencing the response to tobacco-induced oxidative stress. Epigenetic regulation of gene 
expression mediated by DNA methylation has been shown for EPAS1 and EPHX1: their 
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hypermethylation and subsequent downregulation been found to be associated with COPD 
pathogenesis (Vucic et al., 2014; Yoo et al., 2015). The most abundant DNA methylation 
enzyme in somatic cells (DNMT1) had been found to mediate carcinogen-induced gene promoter 
hypermethylation in lung epithelial cells (Damiani et al., 2008). EPAS1 is a key regulator in 
downstream signaling, affecting many of the genes related to COPD, and its protein levels are 
lower in human COPD lung tissue (Yoo et al., 2015). EPHX1 is upregulated by CSE in healthy 
lung epithelial cells (Liu et al., 2010), but it has reduced expression levels in the airways of 
COPD patients, likely mediated by DNA methylation (Vucic et al., 2014).  
Fig. 3.14 Epigenetic effect of procyanidin B2: 
Relative mRNA expression levels of a) EPHX1, 
b) EPAS1, and c) DNMT1 after SAE cells were 
not treated (open bars) or treated (bold bars) 
with CSE after procyanidin B2 was added (50 
μM) or not (control) or. Data is obtained from 
three independent cell experiments; no 
statistical difference is achieved at P < 0.05 by 
Student’s t-test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In the current project, procyanidin B2 displayed strong anti-inflammatory activity and 
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epigenetic effect by modifying the expression of DNMT1, EPAS1 and EPHX1. Acute CSE-
treatment in healthy SAE cells did not lead to significant upregulation in the expression of 
EPHX1 and EPAS1 (Figure 3.14). Application of procyanidin B2 seemed to attenuate the 
expression of both EPAS1 and EPHX1, but no statistical significance was achieved. CSE 
treatment led to slight decrease in DNMT1 expression, further reduced after the application of 
procyanidin B2, but none of the changes were statistically significant. A larger sample size (more 
experimental replicates) may be necessary to provide enough statistical power to find 
significance. 
To our knowledge, procyanidin B2 has not been tested for its effect on EPAS1, EPHX1 
and DNMT1 expression, previously. These results should be regarded within the context of 
healthy lung cells and may provide useful background information for further studies evaluating 
the epigenetic effects of procyanidins in diseased cells or patients with COPD. In healthy cells, 
CSE increases the oxidative burden so slight upregulation of anti-oxidant genes EPAS1 and 
EPHX1 has been reported (Liu et al., 2010). Previous reports have demonstrated a prolonged 
exposure to CSE reduces DNMT1 up to 80% (Liu et al., 2010), and blueberry polyphenolic-
enriched extract (25 μg/mL) and individual phytochemicals sulforaphane and apigenin inhibit 
DNMT1 expression (Kermani, 2012; Qin et al., 2016) while procyanidin B2–3,3’-di-O-gallate 
attenuates DNMT1 activity (Shilpi et al., 2015). Therefore, our results for the effect of 
procyanidin B2 on DNMT1 expression in healthy SAE cells are not surprising. In tobacco-
induced lung cancers, increased expression of DNMT1 has been correlated with 
hypermethylation of tumor suppressor genes (Kim et al., 2006). It will be of particular interest to 
explore procyanidins’ ability to downregulate aberrant expression of DNMT genes or to inhibit 
DNMT1 protein activity in cells from COPD patients.   
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3.10. IL-8 inhibition by procyanidin-derived metabolites  
Direct absorption of oligomeric procyanidins is limited. Minor amounts of procyanidin 
dimers and trimers have been shown to cross the intestinal barrier intact (Ou et al., 2012; Sano et 
al., 2003) but when taken with tetrameric procyanidins, absorption of B2 in rats was enhanced 
(Appeldoorn et al., 2009). Still, less than 10% of dimers degrade to more readily absorbed 
monomers (Stoupi et al., 2010), and most of the oligomers reach the colon where they undergo 
conversion to various metabolites by the microbiota (Llano et al., 2015). Research on the 
potential biological effects of these microbial metabolites is scarce. A study of metabolites of 
oligomeric procyanidins A2 and B2 after anaerobic fermentation with human microbiota showed 
that the A-type dimer is more resistant to microbial catabolism than the B-type (Ou et al., 2014). 
That study also revealed a unique metabolite, 3,4-dihydroxyphenylacetic acid (m3), in the 
fermented broth of dimers procyanidin B2, A2, and apple, and cranberry procyanidins missing 
from the catabolism of monomeric catechins so that compound was further tested in the current 
project (m3). The most common microbial metabolite identified from all procyanidins samples 
was benzoic acid, which is a precursor for hippuric acid (m1) and 2,3-dihydroxybenzoic acid 
(m2) found to be the most abundant plasma metabolites in humans after consumption of 
cranberry juice were and (Feliciano et al., 2016). A study of procyanidin-rich cocoa powder 
consumption found that co-consumption with milk verses water, decreased the plasma 
concentration of compounds m1 and m3 decreased, while increasing that of vanillic acid (m4) 
(Urpi-Sarda et al., 2010) so all four m1-m4 were further tested at 10 μM for their ability to 
decrease IL-8 levels in CSE-treated SAE cells.  
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Fig. 3.15 Procyanidin metabolites counter cigarette smoke extract (CSE) - induced 
inflammation: SAE cells were not treated (open bars) or treated (bold bars) to CSE. IL-8 levels 
were measured after treatment with 10 μM oligomeric-derived metabolites. Results are expressed 
as the mean ± SD from three independent experiments (n = 3. m1 - hippuric acid, m2 - 2,3 
dihydroxybenzoic acid, m3 - 3,4-dihydroxyphenylacetic acid, m4 - vanillic acid. * indicates 
significant difference from CSE-induced vehicle (grey bar),
 
* P < 0.05 by Student’s t-test 
 
Hippuric acid (m1) significantly lowered IL-8 levels in CSE-treated cells while m4 had the 
lowest anti-inflammatory activity (Figure 3.15). Previously, m3 has also been shown to 
significantly inhibit pro-inflammatory cytokines (TNF-a, IL-1b and IL-6) in LPS-stimulated 
peripheral blood mononuclear cells (Monagas et al., 2009). In addition, milk co-consumption 
with procyanidin-rich foods decrease plasma levels of the metabolites with higher IL-8 
inhibition, m1 and m3, while increasing the levels of the least anti-inflammatory compound, m4. 
Therefore, milk co-consumption may reduce the overall anti-inflammatory potency of 
procyanidins, which should be taken into consideration in future animal and human studies of 
procyanidin supplementation. 
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4. Conclusions 
Chronic obstructive pulmonary disease is characterized by dominant inflammatory 
mediators, proteases, and reactive oxygen. In small alveolar epithelial cells (SAE) exposed to 
cigarette smoke extract (CSE), an oligomeric procyanidin-enriched fraction from cranberries 
showed stronger anti-inflammatory potential compared to the same fraction from other 
Vaccinium berries. The study improves dereplication workflow for the discovery of active 
compounds from natural products in two ways. First, it emphasizes the importance of similarity 
of samples in comparisons, which could reduce false positive unique markers. Second, it adds 
transient activity of samples as another dimension to tailor comparisons toward activity-related 
analysis. Combination of two binary OPLS-DA comparisons yielded top-ranked overlapping 
markers with relative abundances, corresponding to low, medium, and high activity of the 
respective fraction. One of the identified markers was tentatively identified as an isomer of 
jaboticabin, a compound that has been previously reported to inhibit IL-8 levels in smoke-
induced SAE cells. This is the first report of jaboticabin presence in several Vaccinium species 
(desugared extracts of their berries) showing its high relative abundance in lingonberry and the 
Bluecrop cultivar of highbush blueberry. Three of the top ranked markers most abundant in the 
active cranberry procyanidin fraction were tested individually in non-treated and CSE-treated 
SAE cells. Procyanidin dimer B2, at 50 µM decreased levels of cytokine IL-8 and expression of 
protease MMP-1 in the CSE-treated cells, while A2 was found to elicit inflammation even 
without CSE exposure. Compound TA, unique for its A-type bond, had slightly weaker anti-
inflammatory activity than B2, and it significantly decreased MMP-1 expression. The other 
cranberry procyanidin A-type trimers merit further investigation because they were also among 
the top ranked markers. The experiments exploring the effect of procyanidin dimer B2 on 
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epigenetic factors and endogenous anti-oxidant enzymes did not yield significant results, but 
could be used as point of reference for future studies using diseased cells.  Procyanidins 
consumed with water, and not milk, lead to microbial metabolite profile that favors increase of 
small phenolic acids such as hippuric acid, which decreased IL-8 inflammatory response to CSE 
in our in vitro model. Oligomeric procyanidins, found in berries, grape seeds, and cocoa powder, 
and their microbial-derived metabolites, could offer a complementary therapeutic strategy to 
current COPD prevention and treatment strategies.  
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Chapter 4: Comparative chemometric strategy to prioritize dietary 
constituents with higher anti-HSV-1 potential from highbush 
blueberry by ultra-high-performance liquid chromatography coupled 
to quadrupole time-of-flight mass spectrometry 
 
1. Introduction 
 Natural products have contributed to drug discovery and continue to be praised for their 
ability to improve consumers’ well-being and health. Novel, bioactive compounds are more 
difficult to discover because of coexistence with known major compounds which have been the 
focus of traditional, activity-guided fractionation. Recently, dereplication strategies employing 
chemometrics have aligned bioactivity of a sample to its unique chemistry yielding numerous 
potentially active markers. Still, these methods require a relatively high number of throughput 
screenings and sample preparation steps. Additionally, ubiquitous OPLS-DA statistical methods 
require samples to be grouped as either active or inactive. An improved comparison method, 
proposed in Chapter 3, narrows down and prioritizes markers with potential activity based on 
reduction of the total number of high relative abundance metabolites in the active sample and 
consideration of intermediate activity level of the samples. In the current study, the method was 
applied to investigate Vaccinium species and their antiviral potential against two Herpes simplex 
viruses type 1 (HSV-1) strains.   
HSV infections are commonly known as oral herpes or cold sores and have also been 
found to cause genital herpes. More severe symptoms and complications occur in 
immunocompromised people. In infants, although cases are rare, HSV-1 infections can lead to 
lasting neurologic disability or even death. More than two thirds of the global population have 
HSV-1 although rates may be underestimated as most infections are asymptomatic (WHO, 
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2017). Recently, a respiratory infection caused by HSV-1 was documented to have occurred in a 
patient who smoked cannabis while having an active oral herpes blister (Libraty, et al., 2014). 
Smoking could provide a route for the virus to enter the lungs and should be discouraged if a 
patient has an active herpes lesion, especially in COPD patients where lower respiratory 
infections increase mortality rates from the disease. Prevention and lowering recurrence of HSV-
1 lesions is typically administered by antiviral medicines, such as acyclovir. However, adverse 
effects and increasing drug-resistance indicates the need for exploration of other antiviral agents 
from natural products that may affect viral adsorption and entry processes (Superti et al., 2008).   
Anti-herpetic properties of Vaccinium species have not been investigated – a search in 
SciFinder produced less than three hits for different combination of search words “Vaccinium”, 
“blueberry”, “herpes”, and “HSV-1”. Still, polyphenols found in these species have been shown 
to produce an antiviral effect in vitro (De Bruyne et al., 1999). This research reports different 
levels of activity between species and cultivars within the Vaccinium genus in addition to 
including activity of some of the pure compounds outlined by the improved strategy.   
2. Materials and methods 
2.1. Chemicals and plant material 
Malvidin 3-O-Glc, quercetin 3-ß-D-glucoside (isoquercitrin), pterostilbene, chlorogenic 
acid, and epicatechin were purchased from Sigma (St. Louis, MO, USA). Procyanidin A2 and 
procyanidin B2 were purchased from Alkemist Labs (Costa Mesa, CA, USA). An isolated 
standard of cinchonain was provided by Dr. Navindra Seeram.  
Blueberry fruits (Vaccinium corymbosum), cultivars Bluegold and Bluecrop were 
collected at the end of July 2011. Additionally, Bluegold cultivar fruits were also collected at the 
end of July 2013. The fruits were harvested and verified for cultivar at the Rutgers University 
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Marucci Center, New Jersey. All fruit was frozen immediately and stored at −20 °C until use. 
Lowbush blueberry (Vaccinium angustifolium) was given as a gift from Dr. David Yarborough at 
the University of Maine. Bilberry (Vaccinium myrtillus) was obtained from a local farmer's 
market in Bulgaria in 2011. Cranberry and lingonberry fruit sources are described in Chapter 3. 
2.2.  Extraction, fractionation, UPLC-QTOFMS and HPLC-TOFMS  
 
Extraction, UPLC-QTOFMS and HPLC-TOFMS methods were performed as described in 
detail in Chapter 3 Methods section. Fractionation was slightly simplified from the method 
described in Chapter 3, following the scheme shown in Fig 4.1 
 
 
Fig. 4.1 Fractionation scheme used to partition three blueberry cultivars. Three major fractions 
were obtained from each of the three highbush blueberry cultivars: Bluecrop (C), Bluegold, 
collected in 2011 (G1), and Bluegold, collected in 2013 (G3). 
 
2.3. MarkerLynx  
Chemometric analysis was performed using the Waters MarkerLynx XS software. Unlike 
in Chapter 3, the sample data used for the analysis was obtained from chromatographic 
separations from UPLC-QTOFMS. Peaks were detected in the negative mode and processed 
following the parameters: 0.5-11.1 min retention time, 100–2000 Da mass range, and mass 
Water wash
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Fr. (3)
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Blueberry crude extract
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tolerance of 0.04 Da. Isotopic peaks were excluded from the analysis, the noise elimination level 
was 4.00, the intensity threshold (counts) was 100, and retention time window was 0.2 min. The 
retention time and m/z data pair for each peak was organized by ApexPeakTrack. The data 
matrix was constructed setting injected samples as the Y variable and marker metabolites as the 
X variable. PCA and OPLS-DA on the data matrix was conducted using SIMCA-P+ built in to 
the MarkerLynx XS platform. Pareto scaling was used with marker ion intensity normalized to 
the total spectral intensity of the individual sample spectrum set to 10,000. 
2.4. Antiviral assays 
Vero (ATCC: CCL 81) cells were grown in Eagle’s minimum essential medium (MEM; 
Cultilab, Campinas, Brazil) supplemented with 10% fetal bovine serum and maintained in 
controlled atmosphere of air - 5% CO2 at 37 °C. HSV-1 [KOS and 29R (acyclovir-resistant) 
strains] were propagated in Vero cells. Viral stocks were titrated as based on plaque forming 
units (PFU) count by plaque assay as previously described (Argenta et al., 2015; Burleson et al., 
1992) and stored at -80°C. 
The screening of cell viability was performed by sulforhodamine B assay (SRB) (Vichai 
& Kirtikara, 2006). Confluent Vero cells were exposed to different concentrations of samples for 
48 h. After incubation, 10% trichloroacetic acid (TCA) was added to each well to fix the cells 
which were then washed and stained with SRB. The protein-bound dye was dissolved in 10 µM 
Tris-Base [tris(hydroxymethyl) aminomethane] solution and optical densities (OD) were read at 
510 nm. The CC50 was defined as the concentration that reduced cell viability by 50% when 
compared to untreated controls.  
To investigate the potency of the detected antiviral activity, a yield reduction assay was 
performed as previously described by (Hussein et al., 2008). Vero cell monolayers were infected 
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with approximately 100 PFU of each virus for 1 h at 37 °C. Cells were washed and overlaid with 
MEM containing 1.5% carboxymethylcellulose (Sigma) either with the presence or absence of 
various concentrations of the samples.  After 48 h (HSV-1) of incubation at 37 °C, cells were 
fixed and stained with naphthol blue–black (Sigma) and plaques were counted. The IC50 was 
defined as the concentration that inhibited 50% of viral plaque formation when compared to 
untreated controls. Acyclovir was used as positive control. The selectivity index (SI = CC50/IC50) 
was calculated for each tested sample. The mean values ± standard deviation represent two or 
three independent experiments.  For the determination of CC50 and IC50 values, nonlinear 
regressions of concentration-response curves were used.  
2.5.Marker prioritization using the improved chemometric approach  
Tables of top-ranked markers from both the typical binary OPLS-DA and the proposed 
combination of two OPLS-DA analysis were created with the markers’ respective retention time 
and major ion mass (RT_m/z) listed in order of decreasing variable importance to the projection 
(VIP) scores. The proposed combination strategy listed the overlapping markers from two 
separate individual OPLS-DA comparisons between i) the two more active samples (one vs. one) 
and ii) the most active against the other two samples (one vs. the rest). The rank order of markers 
from the combination comparison is kept as in one vs. one OPLS-DA analysis. The top markers 
from the traditional binary comparison are shown in column “Binary” and the top overlapping 
markers from the improved approach are displayed in column “Combination”, in Table 4.2.  
3. Results 
3.1. Active compounds from three highbush blueberry cultivars 
Three Blueberry cultivars were fractionated to obtain fractions (1), (2), and (3) from each 
cultivar (Figure 4.1). Their antiviral activities against KOS strain and the acyclovir resistant, 29R 
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strain, of HSV-1 are shown in Figure 4.2. Traditional activity-guided fractionation compares 
fractions from the same sample, such as across fractions from the same cultivar, as shown in 
Figure 4.2 (horizontal arrow). Different groups of compounds are enriched in each fraction 
depending on the stationary and mobile phase of the chromatographic procedure. Therefore, the 
three fractions from the same cultivar would have very different chemical profiles including 
presence of many unique compounds with specific concentration and activity levels. If several 
compounds have activity, but some of them are minor constituents and happen to be in a less 
active fraction, they would be overlooked by traditional activity-guided fractionation which 
would further explore only the subfractions from the most active fraction. The improved strategy 
from Chapter 3 takes a different approach: it identifies potentially active compounds from each 
class by comparing parallel fractions obtained by the same chromatographic procedure from 
different samples (cultivars). Therefore, it analyzes differences among parallel fractions enriched 
in the same class of compounds across the three cultivars (Figure 4.2, vertical arrow). For 
example, the improved strategy would outline potentially active markers in fraction (1) of 
cultivar C, which would be disregarded by horizontal comparison across fractions where fraction 
(3) of cultivar C would be considered the most active.   
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Fig 4.2 Activity against 
HSV-1 by fractions 
from three highbush 
blueberry cultivars: 
Selective index for a) 
KOS strain and b) 
acyclovir resistant 29R 
strain of HSV-1 of three 
fractions from each of 
three highbush blueberry 
cultivar collections: 
Bluegold collected in 
2011 (G1), Bluecrop, in 
2011 (C), and Bluegold, 
in 2013 (G3).  
 
 
 
 
 
 
 
 
 
Selected compounds were tested for activity alone and literature review was performed 
for other identified markers. Parallel fractions (1) were analyzed according to their activity 
against KOS strain only as none of them were active against 29R. The most active fraction (1) 
against the KOS strain was from cultivar C, while intermediate activity was from G1, and lowest, 
from G3 (Table 4.1). 
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Table 4.1 Antiviral activity of fractions (1) from the three blueberry cultivars against HSV-1 
(KOS and 29R strains)   
 
Values represent the mean ± standard deviations of three independent experiments; 
a CC50 = 50% cytotoxic concentration for Vero cells  
b CI50 = 50% concentration that inhibited viral replication  
c Selectivity index SI = CC50/IC50 
*Viral strain sensitive to acyclovir, **Viral strain resistant to acyclovir 
na – no activity 
 
Table 4.2 Fractions (1) 
comparison of marker ranks 
between binary and 
combination comparisons 
based on the anti-HSV-1 
activity from the three 
blueberry cultivars against the 
KOS strain. Top-rated markers 
between typical comparison of 
active verses non-active 
samples are shown on the left 
side, while the overlapping 
markers between two 
individual comparisons, 
accounting for median activity 
level (C > G1 overlap with C, 
G1 > G3) are shown on the 
right. Markers in bold are 
discussed further in the text. # 
denotes the rank number. 
 
 
 
Cinchonain was identified as one of the marker compounds (Table 4.2). Previously it has 
been found in blueberry flowers and leaves (Wan et al., 2012; Wang et al., 2015), but to our 
(µg/mL) (µg/mL) (µg/mL)
CC50
a
IC50
b
SI
c
IC50
b
SI
c
G1 80.01±2.19 37.30±0.96 2.1 na -
C 69.22±11.30 18.80±0.14 3.7 na -
G3 62.92±9.01 na - na -
Fr. 1
HSV-1 (KOS strain)* HSV-1 (29R strain)**
Sample
 C > G1  C, G1, > G3 
 markers  VIP #  markers  VIP  VIP 
1.99_353.0866 10.9 1 9.37_329.2321 5.2         8.7                    
1.99_707.1815 10.1 2 8.96_327.2165 4.0         7.6                    
9.37_329.2321 8.7   3 10.32_293.2112 2.5         6.5                    
8.96_327.2165 7.6   4 1.98_289.0701 1.1         5.9                    
4.21_463.0870 6.8   5 10.46_295.2269 2.8         5.1                    
10.32_293.2112 6.5   6 10.16_311.2218 2.0         4.6                    
1.98_289.0701 5.9   7 7.50_263.1278 7.2         4.5                    
3.70_397.1130 5.3   8 9.73_327.2166 0.9         4.0                    
10.46_295.2269 5.1   9 5.98_451.1019 2.8         3.9                    
4.21_927.1826 4.9   10 7.47_451.1021 1.1         3.4                    
5.83_447.0922 4.8   11 10.57_293.2113 2.2         3.2                    
6.24_507.1133 4.7   12 9.71_329.2326 1.4         3.0                    
1.99_191.0551 4.6   13 10.39_291.1960 1.3         2.5                    
 Fraction 1 
C, G1 > G3
Binary  Combination 
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knowledge this is the first report of its occurrence in the berries of the highbush blueberries. The 
cinchonain standard (65% purity) was graciously provided by Dr. Navindra Seeram at the 
University of Rhode Island. It was found to exert moderate antiviral activity in our bioassay (SI 
> 10, KOS strain). This is the first report of cinchonain’s anti-HSV-1 activities in vitro. 
Cinchonain marker (5.98_451.1019) was upgraded to 9th place by our improved combination 
method (Table 4.2). 
A marker that ranked 1st in the binary strategy (1.99_353.0866) did not appear among the 
markers in the combination strategy. It was identified as chlorogenic acid by co-injection of 
standard and mass fragment data. It was reported to have weaker activity against HSV-1 virus 
than quercetin derivatives (De Almeida et al., 1998). Chlorogenic acid, while affecting 
replication of the virus without being cytotoxic, exerts weaker activity compared to caffeic acid 
and other flavanols (Chiang et al., 2002; De Almeida et al., 1998).  
On the other hand, catechin (1.98_289.0701) identified by parent mass and co-injection 
of standard moved from 7th to 4th place, and has been reported to exert strong HSV-1 activity 
(Lyu et al., 2005). In the same report, epicatechin had much weaker ability; in our assay it 
showed none (Fig. 4.7) and does not appear in the top-ranked markers list.  
Next, the antiviral results from fractions (2) showed that only the cultivar C fraction was 
active against the 29R strain, which creates only two possible sample groups: active and inactive. 
Therefore, no comparison was drawn between the traditional binary OPLS-DA and the proposed 
combination strategy (accounting for intermediate level of activity) relative to the 29R strain.  
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Table 4.3 Antiviral activity of fractions (2) from the three blueberry cultivars against HSV-1 
(KOS and 29R strains)  
  
Values represent the mean ± standard deviations of three independent experiments; 
a CC50 = 50% cytotoxic concentration for Vero cells  
b CI50 = 50% concentration that inhibited viral replication  
c Selectivity index SI = CC50/IC50 
*Viral strain sensitive to acyclovir   **Viral strain resistant to acyclovir 
na – no activity 
 
Parallel fractions (2) from the three blueberry cultivars were analyzed based on their 
activity against the KOS strain: fraction (2) from cultivar C was the most active, followed by 
fraction (2) from cultivar G3, while fraction (2) from cultivar G1 was inactive (Table 4.3). 
Therefore, the combination markers for fractions (2) in Table 4.4 resulted from the overlap 
between OPLS-DA binary comparisons among fractions (2) from G3, C vs. G1 and G3 vs. C. 
Data from positive ionization mode runs was used because fraction (2) was enriched in 
anthocyanins, which are better detected in positive ionization mode. 
Table 4.4 Fractions (2) 
comparison of marker ranks 
from between typical binary 
OPLS-DA and proposed 
combination comparison based 
on the anti-HSV-1 activity from 
the three blueberry cultivars 
against the KOS strain.  
Markers in bold are discussed 
further in the text. # denotes the 
rank number. 
 
 
(µg/mL) (µg/mL) (µg/mL)
CC50
a
IC50
b
SI
c
IC50
b
SI
c
G1 60.84±7.11 na - na -
C 77.28±4.02 38.23±3.61 2 30.38±8.42 2.5
G3 95.64±35.71 31.02±1.35 3.1 na -
HSV-1 (KOS strain)* HSV-1 (29R strain)**
Sample
Fr. 2
 G3 > 
C  G3, C > G1 
 markers  VIP #  markers  VIP  VIP 
a)
11.04_410.2620 11.5  1 2.00_479.1176 4.7      2.5                  
10.93_501.3391 7.3    2 1.77_465.1020 4.4      4.4                  
b)
2.56_431.1910 4.5    1 4.35_137.0222 1.5      2.2                  
… …
4.35_137.0222 1.5    15
 Fraction 2 
Binary  Combination 
G3, C > G1
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Out of the top 70 highest ranked markers, only two overlapped from our combination 
strategy shown in the right columns of Table 4.4 and were identified as glucosides or 
galactosides of petunidin (rank #1) and delphinidin (rank #2) as per characteristic 
parent/fragment ions masses (Prior et al., 2001). Literature about their HSV-1 activities could not 
be found.  
Analysis of chromatographic runs in negative ionization mode resulted in only one 
overlapping marker, which went up from 15th place in the binary to 1st place in the combination 
method. It was tentatively identified by parent and fragment ions in positive mode as acetylated 
malvidin 3-O-Glc (m/z=535.1445) and confirmed by its maximum absorbance at 520nm. An 
available non-acylated anthocyanin standard, malvidin 3-O-Glc, was tested, but exhibited no 
antiviral activity in our study. Further studies need to explore the possibility of anthocyanins 
acting synergistically with other compounds and to clarify whether acylation may contribute to 
antiviral potential. Interestingly, the first marker given by the binary comparison among fraction 
2 from the negative ionization mode runs was chlorogenic acid, identified by co-injection of 
standard and mass fragment data (4.3 b). It was ranked lower by the combination method, and 
has been reported in literature to have weaker activity against HSV-1 virus than quercetin  
derivatives (De Almeida et al., 1998).   
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Fig. 4.3 UPLC-MS-ESI-qTOF chromatograms in negative mode with parent ion scan for cultivar 
fractions (above) and standard compounds (below). Cinchonain standard is 70% pure by AUC in 
the total ion chromatogram, shown at the bottom of c). 
 
In all tests, it was observed that the same fraction had a higher selective index for the 
KOS strain compared to its selective index for the 29R strain. This trend suggests that the 
compounds active against the more resistant 29R strain could be also active against the non-
resistant KOS strain, while those that are active against KOS would not necessarily be active 
against the more resistant 29R strain. Therefore, our analysis focused on activity of samples from 
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BG11_Pac_2_N 1: TOF MS ES- 
463.087 0.0500Da
1.20e4
4.22
4.05
4.47
5.51
Quer3oglcpyranoside_2 1: TOF MS ES- 
463.087 0.0500Da
1.54e4
4.50
BG11_Oli_2_N 1: TOF MS ES- 
353.087 0.0500Da
2.30e5
1.98
2.38
ChlorogenicAcid_less01mg 1: TOF MS ES- 
353.086 0.0500Da
1.70e5
1.99
BC_Oli_2_N 1: TOF MS ES- 
451.102 0.0500Da
4.52e4
5.985.82
4.08 6.87
cinchonain_N 1: TOF MS ES- 
451.074 0.0500Da
5.24e4
5.82
4.90
6.90
cinchonain_N 1: TOF MS ES- 
TIC
1.78e5
5.82
4.90
3.483.211.96 2.84 4.36
4.13
5.21
6.906.59
a)
b)
c)
cinchonain
chlorogenic acid
Quercetin 3-β-
D-glucoside
Quercetin 3-
O-galactside
G1_fr3
G1_fr1
C_fr1      
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fraction (3) against the 29R strain (G1>>G3>C), searching for compounds, potentially active 
against both virus strains.   
Table 4.5 Antiviral activity of fractions (3) from the three blueberry cultivars against HSV-1 
(KOS and 29R strains). 
  
Values represent the mean ± standard deviations of three independent experiments; 
a CC50 = 50% cytotoxic concentration for Vero cells  
b CI50 = 50% concentration that inhibited viral replication  
c Selectivity index SI = CC50/IC50 
*Viral strain sensitive to acyclovir, **Viral strain resistant to acyclovir 
 
 The binary OPLS-DA analysis of fractions (3), in which active sample G1 was compared 
to inactive group of G3 and C, a marker identified as ursolic acid (10.98_455.3512) did not 
appear in the first 15 markers. The combination analysis, overlapping markers from two OPLS-
DA comparisons (G1, G3 > C and G1 > G3) upgraded that marker to 15th place. Ursolic acid, a 
pentacyclic triterpene, was reported to exert HSV-1 activity in vitro (SI =15.2) (Chiang et al., 
2005) and was recently detected in cranberry, eluting at 90% methanol, at the end of the run 
(Murphy et al., 2003). In the current study, the tentatively identified ursolic acid also eluted at 
the end of the run (RT = 10.97min) with one hundred percent acetonitrile. Its relative 
concentration was highest in the acetone fraction (3).  
As seen in Table 4.6, both the binary and combination methods yielded the same top 
marker (4.21_463.0865), tentatively identified as quercetin 3-O-galactoside by parent and 
fragment ions, injection of its isomer, standard quercetin 3-β-D-glucoside, and literature of 
elution order and occurrence (Fig. 4.3 a) (White et al., 2011). The available standard quercetin 3-
β-D-glucoside was also found to be more abundant in the most active fraction (3) of G1 
(µg/mL) (µg/mL) (µg/mL)
CC50
a
IC50
b
SI
c
IC50
b
SI
c
G1 58.55±6.97 11.91±0.16 4.9 11.61±1.15 5
C 57.95±9.57 6.75±0.46 8.6 21.60±1.86 2.7
G3 40.9±10.16 2.88±0.99 14.2 14.83±5.33 2.8
Fr. 3
HSV-1 (KOS strain)* HSV-1 (29R strain)**
Sample
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compared to parallel fractions (3) of C and G3. Quercetin 3-β-D-glucoside has been reported to 
have greater anti-influenza activity in vitro and in vivo compared to quercetin derivatives (Thapa 
et al., 2012) so it was selected for further testing in the antiviral assay. Among all the tested 
compounds in the current project, quercetin 3-β-D-glucoside exhibited the most antiviral 
potency, for both HSV-1 strains, with a notable activity against the acyclovir-resistant strain 29R 
(SI=294) (Table 4.7).  
Table 4.6 Fractions (3) 
comparison of marker 
ranks from typical and 
proposed OPLS-DA 
comparisons based on 
anti-HSV-1 activity from 
the three blueberry 
cultivars against the 29R 
strain. Markers in bold are 
discussed further in the 
text. # denotes the rank 
number 
 
 
 
 
 
 
To investigate a suggested structure-activity relationship between a double linkage and 
antiviral activity (De Bruyne et al., 1999), procyanidin dimers A2 and B2 were included in the 
study, along with other compounds of interest occurring in blueberries (e.g., pterostilbene, 
epicatechin, malvidin 3-O-Glc). Indeed, dimer A2 was found to be active, while dimer B2 did 
not show any activity (Table 4.7), thus the A-type trimers could merit further investigation into 
 G1, G3 > C  G1 > G3 
 markers  VIP #  markers  VIP  VIP 
4.21_463.0865 2.7    1 4.21_463.0865 3.6                  2.7               
10.74_353.2108 2.6    2 10.74_353.2108 4.0                  2.6               
10.76_299.2576 2.3    3 5.10_433.0764 3.0                  2.2               
9.99_309.1695 2.2    4 4.48_463.0874 2.6                  1.9               
5.10_433.0764 2.2    5 5.84_447.0923 2.2                  1.6               
4.48_463.0874 1.9    6 7.71_301.0344 1.8                  1.6               
9.53_221.1170 1.7    7 8.69_345.0603 2.1                  1.6               
5.84_447.0923 1.6    8 10.88_387.1543 2.0                  1.3               
7.71_301.0344 1.6    9 10.94_277.2157 1.7                  1.3               
8.69_345.0603 1.6    10 10.46_471.3465 1.8                  1.3               
10.72_311.1990 1.5    11 10.93_355.2255 1.8                  1.2               
11.02_681.2948 1.4    12 10.01_487.3410 1.7                  1.2               
10.53_337.2046 1.4    13 5.12_363.0710 1.5                  1.0               
10.88_387.1543 1.3    14 11.01_911.7057 1.4                  1.0           
10.94_277.2157 1.279 15 10.98_455.3512 1.8                  1.0               
 Fraction 3 
Binary
G1, G3 > C
 Combination 
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their antiviral potential. Pterostilbene, another health-related compound found in certain 
blueberry species also exhibited slight anti-HSV-1 activity in this study.  
Table 4.7 Anti-HSV-1 activity against KOS and 29R viral strains by selected pure compounds. 
 
  HSV-1 (KOS strain) * HSV-1 (29R strain) ** 
Compound CC50 (µg/mL) a IC50 (µg/mL) b SIc IC50 (µg/mL) b SIc 
Quercetin 3-ß-D-glucoside 55.96±17.19 0.7±0.09 80 0.19 294 
Cinchonain >100 9.42±4.08 >10 9.02 >11 
Procyanidin A2 >100 10.31±3.64 >9 15.09 >7 
Pterostilbene 50.97±12.71 9.42±0.44 5.4 9.87±2.01 5.2 
Epicatechin 346.33±12.46 Na  -   na - 
Procyanidin B2 97.67±20.46 Na  -   na - 
Malvidin 3-O-Glc 175.97±47.00 Na  -   na - 
Acyclovir >1000 0.55±0.08 >1810  -  - 
 
Values represent the mean ± standard deviations of three independent experiments;  
a CC50 = 50% cytotoxic concentration for Vero cells  
b CI50 = 50% concentration that inhibited viral replication  
c Selectivity index SI = CC50/IC50 
*Viral strain sensitive to acyclovir   **Viral strain resistant to acyclovir 
na – no activity 
 
4. Conclusions 
The proposed strategy from Chapter 3 was tested using parallel fractions from three 
highbush blueberry cultivars and their antiviral activities. In comparison to traditional OPLS-DA 
binary comparisons, the proposed combination analysis ranked the active ursolic acid and 
catechin higher, while excluding the less active chlorogenic acid. Out of the tested compounds, 
quercetin 3-β-D-glucoside was found to be the most active for both HSV-1 strains. The 
combination analysis suggested cinchonain as a potent antiviral compound leading to its 
identification in the fruits of highbush blueberries for the first time.  
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Chapter 5: Conclusions 
 
Nature provides a remarkable collection of secondary metabolites that have served as 
primary leads for modern medicines (Newman et al., 2016). Over the last few decades, newly 
registered anti-inflammatory chemical entities have been largely outnumbered by anti-infective 
and antitumor compounds (Newman & Cragg, 2016). Aberrant inflammation due to poor diet 
and tobacco smoking is an underlying factor for many chronic diseases (Blendon et al., 2010; 
King, 2015).  
Tobacco smoking is the primary risk factor for chronic obstructive pulmonary disease. 
This thesis emphasized the urgent need of antitobacco campaigns in Eastern European countries, 
like Bulgaria. From our analysis of publicly available data, Bulgaria was found to have one of 
the highest rates of young female smokers in the world. Most young people who smoke would 
fall in the experimenter group category. Data from the conducted survey on smoking habits 
among college-aged students revealed the high sensitivity of the experimenters to reward 
responsiveness and fun seeking. COPD awareness questions suggested that having a family 
history of COPD might discourage cigarette use but more data is necessary to determine such 
association. Experimenters were the group least interested in learning about COPD and they also 
reported eating antioxidant-rich foods, such as berries and fish less often than others. Taken 
together, these results show that future smoking cessation and prevention strategies could have a 
greater health impact if they (i) are tailored to the specific behavioral sensitivities of the target 
group, (ii) increase the awareness of smoke-related diseases, such as COPD, and (iii) encourage 
health-promoting activities like plant-based, antioxidant-rich food consumption.  
A diet rich in fruits and vegetables has been shown to be positively associated with 
treatment and prevention of COPD (Shaheen et al., 2010; Tabak et al., 2001). Yet, 
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supplementation with an individual antioxidant constituent of such diet, like vitamin C, could not 
significantly slowdown the decline of lung function in patients with COPD (Wu et al., 2007). 
Plant foods, especially apples, have also been shown to exert an important preventive influence 
in a population at high risk of lung cancer, while supplementation with ß-carotene and vitamin A 
increased, rather than decreased, lung cancer incidence and mortality (Neuhouser et al., 2003). 
Therefore, smokers and the elderly who are predisposed to COPD may be referred to a plant-
based diet, which implies the intake of many bioactive natural products (Burns et al., 2000). This 
thesis includes a review of the phytochemical and bioactivity literature of different polyphenol 
classes of compounds predominant in the Vaccinium berries, such as cranberries and blueberries. 
Consumption and production trends of these berries are also summarized. Frozen, organic, 
lowbush blueberries marketed as wild blueberries could present a good alternative to pricey, 
fresh, highbush blueberries due to the former having higher antioxidant capacity and lower cost.  
Consumers recognize the North American blueberry (V. corymbosum) as a “superfood” 
due to its rich content of vitamins, minerals, and anti-oxidant polyphenols (Petrova & Kennelly, 
2013). Blueberries are well-researched species, especially for their colored, highly antioxidant 
compounds – the anthocyanins. Yet, the health benefits from blueberry consumption extend 
beyond the antioxidant effects of anthocyanins. The current studies found that compared with a 
blueberry desugared extract, cranberry and lingonberry samples exhibited a higher anti-
inflammatory potency. Cranberries (V. macrocarpon) have been used by Native Americans to 
delay lipid oxidation in meat preservation techniques (Kä et al., 1999) and lingonberries (V. vitis-
idaea) have been used in European folk medicine for different ailments. Cranberries and 
lingonberries differ from blueberries in that they have A-type procyanidins. The project has 
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demonstrated for the first time the anti-inflammatory potential of cranberries and lingonberries 
and some of their procyanidin compounds in relation to chronic obstructive pulmonary disease. 
In recent years, cutting-edge analytical chemical techniques coupled with advanced 
statistical methods and bioassay profiling have led to the development of chemometric 
approaches in natural product discovery (Boccard et al., 2014; Fujimura et al., 2011; Wolfender 
et al., 2015). Supervised and unsupervised multivariate methods have been used to pinpoint 
compounds with concentrations correlating with a certain sample property. This work proposes 
two improvements in the chemometric approach for natural product discovery. By setting up 
comparisons among samples with similar phytochemical profiles, but varied bioactivities, the 
total potentially active markers could be reduced. Furthermore, while traditional comparison by 
orthogonal projections to latent structures discriminant analysis (OPLS-DA) allows separation of 
samples to only two categories - active or inactive, the approach used here prioritized marker 
compounds by their relevant abundance not only corresponding to samples with low and high, 
but also to samples with medium bioactivity.  
The novel approach led to the identification of 12 overlapping marker compounds, of 
which procyanidin dimers B2, A2, and an A-type trimer were tested individually for the first 
time, to our knowledge, in a smoke-exposed small airway epithelial cell model. Procyanidin 
dimer B2 and the isolated A-type trimer significantly downregulated the expression of smoke-
induced protease MMP-1 and reduced inflammatory marker IL-8, showing their potential in 
COPD treatment. In contrast, procyanidin A2 was found to be proinflammatory even without 
CSE exposure. Therefore, future clinical studies with cranberry supplementation targeting anti-
inflammatory response should consider excluding dimer A2 from the extract or obtaining an 
extract only from the cranberry skin, which have high procyanidins content, except for dimer A2 
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(Grace et al., 2012). The improved lung function from apple consumption (Tabak et al., 2001) 
could be attributed to procyanidin dimer B2, which has been proposed to be mainly responsible 
for the anti-inflammatory activity of apple juice extract (Jung et al., 2009). Procyanidin dimer B2 
was also the most active compound tested in the current smoke-exposed SAE cell model. Future 
studies are necessary to investigate the clinical relevance of procyanidin B2 for COPD. 
Furthermore, the individual anti-inflammatory contribution of other cranberry A-type trimers 
should also be explored as procyanidins have been shown to exert different levels of bioactivity 
according to their specific structure (Dudek et al., 2017). Procyanidin oligomers may contribute 
to the overall role of cranberry extract in the prevention and treatment of lung diseases.  
High rediscovery rates are unavoidable when studying a well-researched species, such as 
blueberries and cranberries. Yet, these commonly consumed berries may exert unrecognized 
health effects by known compounds via novel biological activities or mechanisms of action. To 
evaluate other health-promoting mechanisms from intake of procyanidin B2, this project also 
studied the effects of this compound on endogenous antioxidant defense systems and certain 
epigenetic factors associated with COPD. Moreover, the project also evaluated the anti-
inflammatory effect of a few microbial metabolites known to increase in human plasma after 
intake of procyanidins (Urpi-Sarda et al., 2010). Procyanidins could further exert prebiotic-like 
effects modulating the bacterial populations in the gastrointestinal tract (Ou & Gu, 2014). 
Procyanidin-rich grape seed extract fed to pigs increased the same class of bacteria, 
Ruminococcacceae, associated with weight loss (Choy et al., 2014). The results show promise 
that procyanidin-rich dietary interventions could contribute to the prevention and treatment of 
COPD through various mechanisms. An additional outcome of this research is the discovery of 
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jaboticabin and its isomer for the first time in the Vaccinium genus by LC-MS analysis of parent 
and fragment mass and retention time comparisons to a jaboticabin reference standard.  
The novel combination method overlaps markers from two separate OPLS-DA 
comparison schemes: one vs. one and one vs rest. It differentiates among three groups of samples 
including not only high and low, but also medium activity, while remaining widely-available and 
user-friendly. The approach was further tested in an antiviral study of blueberry cultivars, which 
led to the identification of cinchonain for the first time in blueberry fruits and established its 
activity against HSV-1. Compared to typical binary OPLS-DA analysis, the method was found to 
rank the more active markers higher. Of the tested compounds, quercetin 3-β-D-glucoside was 
found to be the most active for the tested HSV-1 strains. Even if most of the highest ranked 
markers from this approach were found to exhibit strong bioactivity, more investigations are 
needed to validate the approach. Furthermore, a preliminary ranking of potentially active 
markers was conducted by support vector regression with weights corresponding to relevant 
sample activity. Such approach could be useful when considering samples with more than three 
different levels of biological activity, such as classification of raspberry cultivars relative to their 
mold susceptibility (Cappellin et al., 2013). Multiclass methods should be further optimized for 
the discovery of bioactive natural products.  
Given the procyanidins ability to counteract smoke-induced effects and to modify the gut 
microbiome and its metabolites, dietary interventions and clinical studies with cranberry 
procyanidins merit further investigation. Antiviral compounds in food could also be a useful 
preventive measure in smokers with active herpes lesion as smoke could provide a route of the 
virus to the lungs (Libraty et al., 2014). The growing popularity and deregulation of marijuana 
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use should encourage more studies on its long-term consumption as well as on the biological 
effects of procyanidins on tissues exposed to marijuana smoke.  
This dissertation work included three Vaccinium species, six highbush blueberry 
cultivars, and 11 fractions, evaluating the bioactivity of nine pure compounds relative to 
pulmonary and viral diseases. Implementing statistical approaches that consider varying levels of 
biological activity among samples with similar phytochemistry could improve the current 
chemometric strategies for natural products discovery. 
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Appendices 
 
Appendix A 
IRB Approval, Revised consent form and flyer and Memorandum 
 
Appendix A.1  
Lehman College Institutional Review Board Approval letter for survey among Lehman College 
students 
 
 
TO:  Ms.  Vanya Petrova     
Biology 
FROM: Dr. John McDonald  
Chairperson 
Lehman College IRB  
 
SUBJECT: IRB Approval - Exemption 
DATE: March 21, 2011 
STUDY: 11-03-016-0141 Assessing smoking and tobacco use among college-aged 
students 
The Lehman College IRB has approved the above study involving humans as research subjects.  
This project is Approved - Exempt Category: 2 - under 45 CFR 46.   
IRB Number:   11-03-016-0141 This number is a Lehman College IRB number that should be 
used on all correspondence with the IRB regarding this study. 
Approval Date: March 21, 2011 
Expiration Date: March 20, 2014 
Consent Form:  If you are using a consent form, all research subjects must use the approved and 
stamped consent form.  You are responsible for maintaining signed consent forms for each 
research subject for a period of at least three years after study completion. 
Mandatory Reporting to the IRB: The principal investigator must report, within five business 
days, any serious problem, adverse effect, or outcome that occurs with frequency or degree of 
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severity greater than that anticipated.  In addition, the principal investigator must report any 
event or series of events that prompt the temporary or permanent suspension of a research project 
involving human subjects or any deviations from the approved protocol.   
Amendments/Modifications: All amendments/modifications of protocols involving human 
subjects must have prior IRB approval, except those involving the prevention of immediate harm 
to a subject.  Amendments/modifications for the prevention of immediate harm to a subject must 
be reported within 24 hours to the IRB.   
If you have any questions, please feel free to contact Lois Levy in the IRB Office at 718-960-
8717. 
 
Appendix A.2  
Revised consent letter informing participants of this research and explaining how their 
anonymity will be protected despite providing their name and email for compensation purposes.  
 
CONSENT TO TAKE PART IN RESEARCH AS A HUMAN SUBJECT 
The University of Texas at San Antonio 
Title of Project:  Assessing Smoking and Tobacco Use Among College Students 
Study sites: UTSA, Lehman College, Barry University 
 
Principal Investigators:  Raymond Garza, Ph.D., Stella Lopez, Ph.D., Michael Baumann, Ph.D. 
You are being asked to participate in a research study.  This form provides you with information 
about the study.  If you would like a copy of this form to keep for your reference, you should 
print this page before beginning.  The Principal Investigator or his/her representative will provide 
you with any additional information that may be needed and answer any questions you may 
have.  Read the information below and ask questions about anything you do not understand 
before you decide whether or not to take part.  Your participation is entirely voluntary, and you 
can refuse to participate or withdraw at any time without penalty or loss of benefits to which you 
are otherwise entitled. 
Funding Source:  Hispanic Association of Colleges and Universities 
What is the purpose of the study?  We are asking you to take part in a study about smoking 
and tobacco use among Hispanic college-aged students.  We want to learn the patterns and 
predictors of smoking and tobacco use among Mexican-American, Puerto Rican, and Cuban-
American young adults. We are also interested in how these compare to smoking and tobacco 
use by non-Hispanic college students.  We are asking you to take part in this study because you 
are a college student. Across the three academic institutions, approximately 1900 people are 
expected to participate.  
What will be done if you agree to take part in this research study? 
The study consists of filling out an online survey about smoking and tobacco use.  If you are a 
current, former, or even a non-smoker, you are eligible to fill out the online survey. 
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You will fill out the survey at your own place, time, and computer.  The survey must be 
completed in one sitting and takes approximately 1 hour.  If you do not have time to complete 
the survey now, close your browser and come back at a time that is more convenient for you. 
Compensation for the study will be done electronically (see below). 
 
What are the possible discomforts and risks?  
There are no known risks at this time.  Filling out the survey may include some fatigue.  These 
are likely and not serious. 
What are the possible direct benefits to the participant for taking part in this research?       
No benefits exist at this time. 
What are the possible benefits to society from this research? 
The knowledge gained from this study may contribute to our understanding of the patterns and 
predictors of smoking and tobacco use among college students, other self-destructive behaviors 
and related attitudes associated with smoking, and will help in identifying, creating, and 
implementing effective prevention and intervention programs directed towards college students 
in general and for the Hispanic group specifically. 
Will there be any costs related to the research? 
None. 
Will there be any compensation for participation?   
Compensation will be a $20.00 credit for Amazon.com, and will be sent to an email address of 
your choice. 
What if you are injured because of the study? 
The University has no plan to provide compensation for a physical or psychological injury. 
If you do not want to take part in this study, what other options are available to you?   Your 
participation in this study is entirely voluntary.  You are free to refuse to be in the study or to 
withdraw from the study at any time.  Your refusal will not influence current or future 
relationships with The University of Texas at San Antonio.  Your refusal to participate will also 
not influence or affect your grade or standing in your class. 
How will your privacy and the confidentiality of your research records be protected? 
Participants’ names are not recorded in the survey.  Although the compensation page will ask 
you for a name and an email address to send the Amazon credit to, the survey itself and the 
compensation page are hosted on separate servers in separate cities. The IP address from which 
you fill out the survey and compensation form will be recorded to verify that your compensation 
request came from an address used to take the survey. However, IPs will be stripped from the 
compensation file once verification has been achieved (7-10 days after you take the survey). We 
are only asking for this information so that we can send you an electronic “gift card” for 
Amazon.com. You will only receive one email from us, and the information collected on the 
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compensation page will not be shared with other parties unless required by law or to verify that 
compensation was sent. 
Your research records will not be released without your consent unless required by law or a court 
order.  Your records may be viewed by the Institutional Review Board, but the confidentiality of 
your records will be protected to the extent permitted by law.  The data resulting from your 
participation may be used in publications and/or presentations but your identity will not be 
disclosed. 
How can you withdraw from this research study and whom should you call if you have 
questions? 
If you wish to stop your participation for any reason, please contact the principal investigator, 
Dr. Raymond Garza at 210.458.4081, Dr. Stella Lopez at 210.458.5731, or Dr. Michael 
Baumann at 210.458.5720 or tell the research personnel.  Throughout the study, the researchers 
will notify you of new information that may become available and that might affect your 
decision to remain in the study.  
If you have questions before you begin, email one of the investigators (Raymond Garza, Ph.D., 
Raymond.Garza@utsa.edu; Stella Lopez, Ph.D., Stella.Lopez@utsa.edu ; or Michael Baumann, 
Ph.D, Michael.Baumann@utsa.edu).  If you have questions later, you may contact Raymond 
Garza, Ph.D. at 210.458.5731, Stella Lopez, Ph.D. at 210.458.5731, or Michael Baumann, Ph.D. 
at 201.458.5720. 
 In addition, if you have questions about your rights as a research subject, or if you have 
complaints, concerns, or questions about the research, you may contact the University of Texas 
at San Antonio Institutional Review Board at (210) 458-6473. 
By clicking “next” below and beginning the survey, you acknowledge you have been informed 
about this study’s purpose, procedures, possible benefits and risks, that you have been given the 
opportunity to ask questions before you begin, and that you voluntarily agree to participate in 
this study.  
By clicking below, you are not waiving any of your legal rights. If you wish, you may print a 
copy of this form to keep.  
If you wish to begin the survey at a later time, simply close your browser and return to this page 
at a time that is more convenient for you.  Thank you
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Appendix A.3  
Script for in-class recruitment and flyer that was posted around Lehman College campus.  
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Appendix A.4  
Lehman College IRB Determination after supplying the revised consent and flyer: 
 
Memorandum 
TO:  Vanya Petrova 
  Dr. Edward Kennelly  
FROM:  Lois Levy, D.M.H. 
  Administrator 
  Institutional Review Board 
DATE: 18 May 2011 
RE:   Protocol 11-03-016 Assessing smoking and tobacco use among college aged 
students 
Thank you for thoroughly answering the IRB’s questions and supplying the revised consent and 
flyer. This has satisfied the IRB’s concerns and you are free to continue with the study.  
John McDonald, Ph.D., Chairman / Lois Levy, D.M.H., Administrator 
Voice: (718) 960-8717        E-mail: lois.levy@lehman.cuny.edu 
 
Appendix B 
Contingency table with survey answers to multiple response question 1 (COPD awareness)  
 
Appendix C 
An example of relative abundances of markers compounds prioritized by the different OPLS-DA 
analysis: 
Marker 1 is prioritized by the improved approach, overlapping two OPLS-DA analysis, and its 
relative concentrations (areas under the curve) in the fractions of cranberry (C), lingonberry (L), 
CU category
Respondents 
(157)
know COPD 
(n=90)
relative COPD 
(n=59)
shows smpt 
(n=8)
at Risk 
(n=8)
learn more 
(n=52)
Responses 
(217)
nonsmoker ( N ) 57 30 23 2 1 24 80
experimenter ( E ) 60 41 25 3 1 14 84
current smoker ( C ) 23 13 5 2 3 8 31
former smoker ( F ) 17 6 6 1 3 6 22
active smokers (E+C) 54 30
not active smokers (N+F) 36 29
Total: 157 217
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and blueberry (B) follow the same order as the anti-inflammatory potency of the fractions: C > L 
> B or, the marker has greatest relative abundance in C (23591), less in L (15082), and least in B 
(under the limit of quantitation). 
Marker 2 is prioritized by the typical binary OPLS-DA comparison (C and L vs. B) and its 
relative concentration is higher in the lingonberry fraction (15053) compared to the cranberry 
one (3935). The relative abundance of marker 2 is L > C > B, which is not the order of anti-
inflammatory potency of the fractions, namely C > L > B.  
 
 
Appendix D 
Additional anti-HSV testing was done in collaboration with the following lab and researchers: 
 
The antiviral assays were performed by Dr. Naira Schneider in the laboratory of  
Dr. Claudia Simões 
Department of Pharmaceutical Sciences 
Federal University of Santa Catarina – UFSC 
Florianópolis, SC, Brazil  
 
purified also with sephadex
Time
10.00 12.00 14.00 16.00 18.00
%
0
100
10.00 12.00 14.00 16.00 18.00
%
0
100
10.00 12.00 14.00 16.00 18.00
%
0
100
oli_Cr_2 Sm (Mn, 2x3) 2: TOF MS ES- 
575.17 0.0500Da
2.93e4
Area
15.86
23591
13.83
3935
oli_Lin_3_1 Sm (Mn, 2x3) 2: TOF MS ES- 
575.17 0.0500Da
2.93e4
Area
15.86
15082
13.98
15053
oli_BG11_1 Sm (Mn, 2x3) 2: TOF MS ES- 
575.15 0.0500Da
2.93e4
Area
L_fr1
C_fr1
B_fr1
marker 1:
15.92_575.1661
(C > L > B)
marker 2:
13.92_575.1566
(L > C > B)
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